https://www.dailyhealthcarestlucia.com/article/914331661-black-diamond-therapeutics-to-participate-in-jefferies-global-healthcare-conference Daily Healthcare St. Lucia en PressRelease 2026-05-22T12:00:00+00:00 Black Diamond Therapeutics to Participate in Jefferies Global Healthcare Conference https://ml.globenewswire.com/media/b8da4d92-789b-4f0a-a1e2-2739af370155/small/bdtxlogo-pantone3135c-png-png.png https://www.dailyhealthcarestlucia.com/article/914331685-phathom-pharmaceuticals-to-participate-in-upcoming-investor-conferences Daily Healthcare St. Lucia en PressRelease 2026-05-22T12:00:00+00:00 Phathom Pharmaceuticals to Participate in Upcoming Investor Conferences https://ml.globenewswire.com/media/0baa6f51-c6cb-4b21-a4e0-573a18b8171c/small/phathom-pharm-logo-jpg.jpg https://www.dailyhealthcarestlucia.com/article/914331686-anavex-life-sciences-receives-expected-nasdaq-delinquency-notification Daily Healthcare St. Lucia en PressRelease 2026-05-22T12:00:00+00:00 Anavex Life Sciences Receives Expected Nasdaq Delinquency Notification https://ml.globenewswire.com/media/1b0f858f-4f7f-4f50-b691-a25307283fb5/small/anavexlogor-transparent-3x-png.png https://www.dailyhealthcarestlucia.com/article/914331787-sbc-medical-and-blez-asia-celebrate-opening-of-new-aesthetic-dermatology-section-at-blez-clinic-in-bangkok Daily Healthcare St. Lucia en PressRelease 2026-05-22T12:00:00+00:00 SBC Medical and BLEZ ASIA Celebrate Opening of New Aesthetic Dermatology Section at BLEZ CLINIC in Bangkok https://ml.globenewswire.com/media/67e1656f-882c-4c8e-bbb6-13bc2933e270/medium/sbc-medical-and-blez-asia-celebrate-opening-of-new-aesthetic.png https://www.dailyhealthcarestlucia.com/article/914331792-2026-asco-pivotal-data-of-innocare-s-novel-bcl2-inhibitor-mesutoclax-released Daily Healthcare St. Lucia en PressRelease 2026-05-22T12:00:00+00:00 2026 ASCO | Pivotal Data of InnoCare's Novel BCL2 Inhibitor Mesutoclax Released https://ml.globenewswire.com/media/2dc70b00-a0b0-4d85-adef-2717a7067aec/small/innocare-eng-logo-horizontal-png.png https://www.dailyhealthcarestlucia.com/article/914331680-briacell-presentations-highlight-positive-clinical-data-for-bria-imt-at-asco-2026 Daily Healthcare St. Lucia en PressRelease 2026-05-22T11:30:00+00:00 BriaCell Presentations Highlight Positive Clinical Data for Bria-IMT™ at ASCO 2026 https://ml.globenewswire.com/media/88b9408d-31d4-4afd-beff-f855719a15d8/small/briacell-logo-square-a-jpg.jpg https://www.dailyhealthcarestlucia.com/article/914331684-repligen-corporation-to-present-at-william-blair-46th-annual-growth-stock-conference Daily Healthcare St. Lucia en PressRelease 2026-05-22T11:30:00+00:00 Repligen Corporation to Present at William Blair 46th Annual Growth Stock Conference https://ml.globenewswire.com/media/967d43f6-7ffd-4ee0-8804-e3c12952402f/small/repligen-logo-horizontal-withtagline-1-jpg.jpg https://www.dailyhealthcarestlucia.com/article/914322031-assembly-biosciences-announces-pricing-of-100-million-offering-of-common-stock-and-pre-funded-warrants Daily Healthcare St. Lucia en PressRelease 2026-05-22T11:05:00+00:00 Assembly Biosciences Announces Pricing of $100 Million Offering of Common Stock and Pre-Funded Warrants https://ml.globenewswire.com/media/33089548-b62b-412d-9343-ae38d8b720c6/small/assemblybio-logo-rgb-png.png https://www.dailyhealthcarestlucia.com/article/914321207-ac-immune-presents-new-phase-1-data-indicating-higher-uptake-of-tdp-43-pet-tracer-aci-19626-in-patients-with-als Daily Healthcare St. Lucia en PressRelease 2026-05-22T11:00:00+00:00 AC Immune Presents New Phase 1 Data Indicating Higher Uptake of TDP-43 PET Tracer ACI-19626 in Patients with ALS https://ml-eu.globenewswire.com/media/0065cdfd-b9fc-4994-8aca-731c1d031b51/small/logo-jpg.jpg https://www.dailyhealthcarestlucia.com/article/914321585-cartigenix-hp-backed-by-three-human-studies-as-clinicians-seek-evidence-based-joint-health-options Daily Healthcare St. Lucia en PressRelease 2026-05-22T11:00:00+00:00 Cartigenix HP® Backed by Three Human Studies as Clinicians Seek Evidence-Based Joint Health Options https://ml.globenewswire.com/media/d7dc39f8-a2af-4bdc-8746-60a8c4c3ddc8/small/calroy-health-sciences-logo-rachel-rowley-png.png https://www.dailyhealthcarestlucia.com/article/914321642-otarmeni-lunsotogene-parvec-receives-ema-filing-acceptance-for-genetic-hearing-loss Daily Healthcare St. Lucia en PressRelease 2026-05-22T11:00:00+00:00 Otarmeni™ (lunsotogene parvec) Receives EMA Filing Acceptance for Genetic Hearing Loss https://ml.globenewswire.com/media/add5ebc7-88c9-49dc-8834-abbb07c622d1/small/regeneron-logo-jpg.jpg https://www.dailyhealthcarestlucia.com/article/914321718-enable-injections-announces-ce-certification-of-the-enfuse-on-body-delivery-system-for-use-with-aspaveli-distributed-by-sobi Daily Healthcare St. Lucia en PressRelease 2026-05-22T11:00:00+00:00 Enable Injections Announces CE Certification of the enFuse® On-Body Delivery System for Use with Aspaveli® Distributed by Sobi https://ml.globenewswire.com/media/f41706a5-9f61-4772-83f1-6aa50c660788/small/enable-injections-logo-png.png https://www.dailyhealthcarestlucia.com/article/914321794-biostem-technologies-announces-2-5-million-private-placement-financing-with-its-first-institutional-investor Daily Healthcare St. Lucia en PressRelease 2026-05-22T11:00:00+00:00 BioStem Technologies Announces $2.5 Million Private Placement Financing with its First Institutional Investor https://ml.globenewswire.com/media/da0ea21a-fd6e-425a-a8f2-6f69dc2b4612/small/biostem-main-logo-png.png https://www.dailyhealthcarestlucia.com/article/914321796-assembly-biosciences-announces-expansion-of-abi-6250-clinical-development-into-cholestatic-liver-diseases Daily Healthcare St. Lucia en PressRelease 2026-05-22T11:00:00+00:00 Assembly Biosciences Announces Expansion of ABI-6250 Clinical Development Into Cholestatic Liver Diseases https://ml.globenewswire.com/media/33089548-b62b-412d-9343-ae38d8b720c6/small/assemblybio-logo-rgb-png.png https://www.dailyhealthcarestlucia.com/article/914321886-medicenna-announces-the-filing-of-its-prospectus-supplement-and-investment-term-sheet Daily Healthcare St. Lucia en PressRelease 2026-05-22T11:00:00+00:00 Medicenna Announces the Filing of its Prospectus Supplement and Investment Term Sheet https://ml.globenewswire.com/media/7e312e67-9924-4773-b548-47ed05d54904/small/new-logo-small-png.png https://www.dailyhealthcarestlucia.com/article/914321869-arch-biopartners-announces-royal-columbian-hospital-has-dosed-its-first-patient-in-its-phase-ii-cardiac-surgery-associated-aki-trial Daily Healthcare St. Lucia en PressRelease 2026-05-22T10:50:00+00:00 Arch Biopartners announces Royal Columbian Hospital has dosed its first patient in its Phase II cardiac surgery-associated AKI trial https://ml.globenewswire.com/media/8fae7e83-0899-4bbc-ba40-0250cdb9aea7/small/logo-png.png https://www.dailyhealthcarestlucia.com/article/914295860-biontech-pr-sentiert-auf-der-asco-jahrestagung-2026-fortschritte-aus-pipelineprogrammen-in-der-sp-ten-klinischen-entwicklung Daily Healthcare St. Lucia en PressRelease 2026-05-22T09:00:00+00:00 BioNTech präsentiert auf der ASCO-Jahrestagung 2026 Fortschritte aus Pipelineprogrammen in der späten klinischen Entwicklung https://ml-eu.globenewswire.com/media/b9e2e00e-f790-4d54-a01f-4c85716b01bd/small/ https://www.dailyhealthcarestlucia.com/article/914295902-biontech-to-showcase-progress-across-late-stage-oncology-pipeline-at-the-2026-asco-annual-meeting Daily Healthcare St. Lucia en PressRelease 2026-05-22T09:00:00+00:00 BioNTech to Showcase Progress Across Late-Stage Oncology Pipeline at the 2026 ASCO Annual Meeting https://ml-eu.globenewswire.com/media/b9e2e00e-f790-4d54-a01f-4c85716b01bd/small/190705-biontech-logo-rgb-dark-green-preferred-0-png.png https://www.dailyhealthcarestlucia.com/article/914280549-china-approves-hernexeos-as-first-targeted-oral-treatment-option-for-her2-mutant-advanced-nsclc-at-initial-diagnosis Daily Healthcare St. Lucia en PressRelease 2026-05-22T07:45:00+00:00 China approves HERNEXEOS® as first targeted oral treatment option for HER2-mutant advanced NSCLC at initial diagnosis https://ml-eu.globenewswire.com/media/f121dfae-77e7-4a01-b1ef-6b757767ddab/small/111boehringer-ingelheim-logo-rgb-dark-green-002-png.png https://www.dailyhealthcarestlucia.com/article/914280532-storm-therapeutics-to-present-promising-phase-1-sarcoma-data-demonstrating-activity-of-first-in-class-mettl3-inhibitor-stc-15-at-asco-2026 Daily Healthcare St. Lucia en PressRelease 2026-05-22T07:30:00+00:00 STORM Therapeutics to Present Promising Phase 1 Sarcoma Data Demonstrating Activity of First‑in‑Class METTL3 Inhibitor STC‑15 at ASCO 2026 https://ml-eu.globenewswire.com/media/1f159389-0c23-4305-b40e-b83e89274cee/small/logo-png.PNG https://www.dailyhealthcarestlucia.com/article/914264116-hanmi-pharmaceutical-se-asocia-con-organon-para-exportar-terapias-combinadas-al-sudeste-asi-tico Daily Healthcare St. Lucia en PressRelease 2026-05-22T06:20:18+00:00 Hanmi Pharmaceutical se asocia con Organon para exportar terapias combinadas al Sudeste Asiático https://ml.globenewswire.com/media/526a18fe-e048-4862-91e5-0a6effeaf8ab/small/hanmi-pharmaceutical-logo-jpg.jpg https://www.dailyhealthcarestlucia.com/article/914264215-hanmi-pharmaceutical-faz-parceria-com-a-organon-para-exporta-o-de-terapias-de-combina-o-para-o-sudeste-asi-tico Daily Healthcare St. Lucia en PressRelease 2026-05-22T06:20:18+00:00 Hanmi Pharmaceutical Faz Parceria com a Organon para Exportação de Terapias de Combinação para o Sudeste Asiático https://ml.globenewswire.com/media/526a18fe-e048-4862-91e5-0a6effeaf8ab/small/hanmi-pharmaceutical-logo-jpg.jpg https://www.dailyhealthcarestlucia.com/article/914264043-angel-introduces-x2-water-filter-system-with-advanced-tankless-7-stage-filtration-and-99-pfas-reduction Daily Healthcare St. Lucia en PressRelease 2026-05-22T05:45:33+00:00 ANGEL Introduces X2 Water Filter System with Advanced Tankless 7-Stage Filtration and 99% PFAS Reduction https://ml.globenewswire.com/media/38ebd348-2161-4e2e-bd81-b7e8c6fd5324/medium/image-1.jpeg https://www.dailyhealthcarestlucia.com/article/914263955-ose-immunotherapeutics-annonce-les-r-sultats-de-topline-positifs-de-l-tude-de-phase-2-tedova-de-tedopi-dans-le-cancer-de-l-ovaire-en-rechute Daily Healthcare St. Lucia en PressRelease 2026-05-22T05:30:00+00:00 OSE Immunotherapeutics annonce les résultats de Topline positifs de l'étude de Phase 2 TEDOVA de Tedopi® dans le cancer de l’ovaire en rechute https://ml-eu.globenewswire.com/media/e79ae2c6-fc13-4a02-9759-4ecc9c4fdb22/small/ https://www.dailyhealthcarestlucia.com/article/914263967-ose-immunotherapeutics-reports-positive-topline-results-of-tedova-phase-2-trial-with-tedopi-in-recurrent-ovarian-cancer Daily Healthcare St. Lucia en PressRelease 2026-05-22T05:30:00+00:00 OSE Immunotherapeutics Reports Positive Topline Results of TEDOVA Phase 2 Trial with Tedopi® in Recurrent Ovarian Cancer https://ml-eu.globenewswire.com/media/e79ae2c6-fc13-4a02-9759-4ecc9c4fdb22/small/ose-logo-horizontal-rvb-png.png https://www.dailyhealthcarestlucia.com/article/914242935-nervgen-announces-pricing-of-us-60-0-million-public-offering-of-securities Daily Healthcare St. Lucia en PressRelease 2026-05-22T03:27:00+00:00 NervGen Announces Pricing of US$60.0 Million Public Offering of Securities https://ml.globenewswire.com/media/bb42d0ef-06b6-4b90-8389-ca991092aa37/small/nervgen-logo-updated-globenewswire-png.png https://www.dailyhealthcarestlucia.com/article/914218852-medline-inc-announces-pricing-of-upsized-secondary-offering-of-class-a-common-stock Daily Healthcare St. Lucia en PressRelease 2026-05-22T02:45:00+00:00 Medline Inc. announces pricing of upsized secondary offering of Class A common stock https://ml.globenewswire.com/media/70e45830-32e3-4232-b15b-7e43c436de41/small/log-medline-1200-630-center-png.png https://www.dailyhealthcarestlucia.com/article/914218482-femicore-claims-evaluated-investigating-the-ingredients-for-bladder-support-femi-core-consumer-complaints-exposed Daily Healthcare St. Lucia en PressRelease 2026-05-22T01:24:10+00:00 FemiCore Claims Evaluated: Investigating the Ingredients for Bladder Support - Femi Core Consumer Complaints Exposed https://zingfast.com/wp-content/uploads/2026/05/FemiCore.jpg https://www.dailyhealthcarestlucia.com/article/914218418-most-effective-magnesium-pain-cream-researched-real-magnesium-niacinamide-relief-for-peak-health-nerve-pain-recovery Daily Healthcare St. Lucia en PressRelease 2026-05-22T01:05:27+00:00 Most Effective Magnesium Pain Cream Researched: Real Magnesium Niacinamide Relief for Peak Health & Nerve Pain Recovery https://zingfast.com/wp-content/uploads/2026/05/Best-Magnesium-Pain-Cream.jpg https://www.dailyhealthcarestlucia.com/article/914190921-liminatus-pharma-announces-nasdaq-delisting-notification Daily Healthcare St. Lucia en PressRelease 2026-05-22T00:28:26+00:00 Liminatus Pharma Announces Nasdaq Delisting Notification https://ml.globenewswire.com/media/9ad52a99-f6dd-4ecb-8aa0-15713a0e8788/small/picture1-png.png https://www.dailyhealthcarestlucia.com/article/914190534-taimed-biologics-completes-phase-2b-enrollment-for-tmb-365-380-in-hiv-maintenance-therapy-study Daily Healthcare St. Lucia en PressRelease 2026-05-22T00:00:00+00:00 TaiMed Biologics Completes Phase 2b Enrollment for TMB-365/380 in HIV Maintenance Therapy Study https://ml.globenewswire.com/media/1cb82885-f089-49cf-9399-8f9e4bc0918c/small/taimed-logo-png.png https://www.dailyhealthcarestlucia.com/article/914190829-hutchmed-highlights-clinical-data-to-be-presented-at-the-2026-asco-annual-meeting Daily Healthcare St. Lucia en PressRelease 2026-05-22T00:00:00+00:00 HUTCHMED Highlights Clinical Data to be Presented at the 2026 ASCO Annual Meeting https://ml.globenewswire.com/media/085957ad-3bec-49ee-b13e-39961b83c7be/small/hutchmed-small-spaced-1000x305-whitebgd-png.png https://www.dailyhealthcarestlucia.com/article/914190865-ascentage-pharma-releases-latest-clinical-data-from-multiple-trials-at-asco-2026 Daily Healthcare St. Lucia en PressRelease 2026-05-22T00:00:00+00:00 Ascentage Pharma Releases Latest Clinical Data from Multiple Trials at ASCO 2026 https://ml.globenewswire.com/media/b9623a51-a13b-4b80-8152-61d5014f4a0a/small/2025-11-12-ascentage-600x600-png.png https://www.dailyhealthcarestlucia.com/article/914163533-fennec-pharmaceuticals-announces-new-research-supporting-integration-and-use-of-pedmark-at-the-2026-asco-annual-meeting Daily Healthcare St. Lucia en PressRelease 2026-05-21T22:01:27+00:00 Fennec Pharmaceuticals Announces New Research Supporting Integration and Use of PEDMARK® at the 2026 ASCO Annual Meeting https://ml.globenewswire.com/media/2eeb9b85-0beb-4bbe-a7af-1c0e9403db44/small/fennec-logo-png.png https://www.dailyhealthcarestlucia.com/article/914163048-biogen-and-denali-therapeutics-provide-update-on-phase-2b-luma-study-of-biib122-dnl151-in-early-stage-parkinson-s-disease Daily Healthcare St. Lucia en PressRelease 2026-05-21T22:00:00+00:00 Biogen and Denali Therapeutics Provide Update on Phase 2b LUMA Study of BIIB122 (DNL151) in Early-Stage Parkinson’s Disease https://ml.globenewswire.com/media/80f9c524-3da2-4583-a763-0dad931fa182/small/biogen-logo-standard-rgb-r-jpg.jpg https://www.dailyhealthcarestlucia.com/article/914163509-biogen-and-denali-therapeutics-provide-update-on-phase-2b-luma-study-of-biib122-dnl151-in-early-stage-parkinson-s-disease Daily Healthcare St. Lucia en PressRelease 2026-05-21T22:00:00+00:00 Biogen and Denali Therapeutics Provide Update on Phase 2b LUMA Study of BIIB122 (DNL151) in Early-Stage Parkinson’s Disease https://ml.globenewswire.com/media/898f19a9-f6ef-4d5a-8a4f-27709b81609a/small/denali-green-logo-png.png https://www.dailyhealthcarestlucia.com/article/914163052-perspective-therapeutics-to-present-data-from-all-clinical-programs-at-the-2026-asco-annual-meeting-including-findings-from-212pb-vmt01-in-melanoma Daily Healthcare St. Lucia en PressRelease 2026-05-21T21:51:13+00:00 Perspective Therapeutics to Present Data from All Clinical Programs at the 2026 ASCO Annual Meeting, including Findings from [212Pb]VMT01 in Melanoma https://ml.globenewswire.com/media/e8b42463-3d31-441e-8c09-6b88826fe1c6/small/persp-jpg.jpg https://www.dailyhealthcarestlucia.com/article/914162936-zentalis-pharmaceuticals-to-present-phase-1b-muir-trial-data-showing-encouraging-clinical-activity-and-manageable-safety-profile-of-azenosertib-plus Daily Healthcare St. Lucia en PressRelease 2026-05-21T21:39:11+00:00 Zentalis Pharmaceuticals to Present Phase 1b MUIR Trial Data Showing Encouraging Clinical Activity and Manageable Safety Profile of Azenosertib Plus Paclitaxel in Platinum-Resistant Ovarian Cancer at ASCO 2026 https://ml.globenewswire.com/media/ecb98bea-7a9f-4319-874c-1911777a5a46/small/zentalis-logo-full-color-png.png https://www.dailyhealthcarestlucia.com/article/914162553-crescent-biopharma-announces-trial-in-progress-presentation-for-ascend-study-of-cr-001-a-pd-1-x-vegf-bispecific-antibody-at-upcoming-american Daily Healthcare St. Lucia en PressRelease 2026-05-21T21:30:00+00:00 Crescent Biopharma Announces Trial in Progress Presentation for ASCEND Study of CR-001, a PD-1 x VEGF Bispecific Antibody, at Upcoming American Society of Clinical Oncology (ASCO) 2026 Annual Meeting https://ml.globenewswire.com/media/57dabf2a-90a3-4786-9c39-d1e71cc7707f/small/crescent-biopharma-logo-color-png.png https://www.dailyhealthcarestlucia.com/article/914163191-pliant-therapeutics-announces-upcoming-presentation-at-the-2026-american-society-of-clinical-oncology-annual-meeting Daily Healthcare St. Lucia en PressRelease 2026-05-21T21:29:30+00:00 Pliant Therapeutics Announces Upcoming Presentation at the 2026 American Society of Clinical Oncology Annual Meeting https://ml.globenewswire.com/media/6a9e3f3f-d4fb-4bf0-9480-3bbd3fd2ced9/small/pliant-logo-300x300-jpg.jpg https://www.dailyhealthcarestlucia.com/article/914162947-aktis-oncology-reports-first-in-human-clinical-imaging-and-dosimetry-data-for-aky-2519-demonstrating-robust-tumor-uptake-and-limited-normal-tissue Daily Healthcare St. Lucia en PressRelease 2026-05-21T21:21:08+00:00 Aktis Oncology Reports First-in-Human Clinical Imaging and Dosimetry Data for AKY-2519 Demonstrating Robust Tumor Uptake and Limited Normal Tissue Exposures in Patients with B7-H3 Expressing Tumors https://ml.globenewswire.com/media/490bbb9a-2b27-4a72-8d7a-333387326d8b/small/aktis-rgb-png.png https://www.dailyhealthcarestlucia.com/article/914162745-jupiter-neurosciences-announces-closing-of-2-0-million-registered-direct-offering Daily Healthcare St. Lucia en PressRelease 2026-05-21T21:15:00+00:00 Jupiter Neurosciences Announces Closing of $2.0 Million Registered Direct Offering https://ml.globenewswire.com/media/4e829d7e-ecf6-46ad-98fe-479755d626e1/small/image-png.png https://www.dailyhealthcarestlucia.com/article/914162747-black-diamond-therapeutics-announces-positive-phase-2-results-for-silevertinib-in-frontline-nsclc-patients-with-egfr-non-classical-mutations Daily Healthcare St. Lucia en PressRelease 2026-05-21T21:13:52+00:00 Black Diamond Therapeutics Announces Positive Phase 2 Results for Silevertinib in Frontline NSCLC Patients with EGFR Non-Classical Mutations https://ml.globenewswire.com/media/b8da4d92-789b-4f0a-a1e2-2739af370155/small/bdtxlogo-pantone3135c-png-png.png https://www.dailyhealthcarestlucia.com/article/914159935-autolus-therapeutics-to-present-clinical-data-update-at-the-american-society-of-clinical-oncology-annual-meeting-2026 Daily Healthcare St. Lucia en PressRelease 2026-05-21T21:10:00+00:00 Autolus Therapeutics to Present Clinical Data Update at the American Society of Clinical Oncology Annual Meeting 2026 https://ml.globenewswire.com/media/680b5e1a-9aba-4e38-b280-e43036561ef1/small/picture1-png.png https://www.dailyhealthcarestlucia.com/article/914159924-remix-therapeutics-announces-positive-data-from-phase-1-2-aria-study-of-first-in-class-myb-mrna-degrader-rem-422-in-patients-with-adenoid-cystic Daily Healthcare St. Lucia en PressRelease 2026-05-21T21:05:00+00:00 Remix Therapeutics Announces Positive Data from Phase 1/2 ARIA Study of First-in-Class MYB mRNA Degrader, REM-422, in Patients with Adenoid Cystic Carcinoma (ACC) at the American Society of Clinical Oncology Annual Meeting 2026 https://ml.globenewswire.com/media/4facea87-f600-4440-a295-a31bb083c9bd/small/remix-logo-png.png https://www.dailyhealthcarestlucia.com/article/914162229-eikon-therapeutics-announces-availability-of-six-abstracts-for-presentation-at-the-2026-annual-meeting-of-the-american-society-of-clinical-oncology Daily Healthcare St. Lucia en PressRelease 2026-05-21T21:05:00+00:00 Eikon Therapeutics Announces Availability of Six Abstracts for Presentation at the 2026 Annual Meeting of the American Society of Clinical Oncology https://ml.globenewswire.com/media/02bfb0a7-27fe-4be6-b2f9-bc6eaf27b1d9/small/eikon-logo-jpg.jpg https://www.dailyhealthcarestlucia.com/article/914162615-moleculin-highlights-abstract-accepted-for-poster-presentation-at-the-2026-asco-annual-meeting-highlighting-cardiac-safety-data-for-annamycin Daily Healthcare St. Lucia en PressRelease 2026-05-21T21:02:00+00:00 Moleculin Highlights Abstract Accepted for Poster Presentation at the 2026 ASCO Annual Meeting Highlighting Cardiac Safety Data for Annamycin https://ml.globenewswire.com/media/7fa09722-2ef8-49fc-bc24-6b150093f8ba/small/mbrx-logo-png.png https://www.dailyhealthcarestlucia.com/article/914162250-lynozyfic-linvoseltamab-monotherapy-demonstrates-deep-and-rapid-responses-in-all-treated-patients-with-second-line-plus-systemic-amyloid-light Daily Healthcare St. Lucia en PressRelease 2026-05-21T21:01:52+00:00 Lynozyfic® (linvoseltamab) Monotherapy Demonstrates Deep and Rapid Responses in All Treated Patients with Second-Line-Plus Systemic Amyloid Light Chain Amyloidosis https://ml.globenewswire.com/media/add5ebc7-88c9-49dc-8834-abbb07c622d1/small/regeneron-logo-jpg.jpg https://www.dailyhealthcarestlucia.com/article/914160115-syndax-announces-four-revuforj-revumenib-abstracts-accepted-for-asco-2026-including-an-oral-presentation-of-post-transplant-data Daily Healthcare St. Lucia en PressRelease 2026-05-21T21:01:00+00:00 Syndax Announces Four Revuforj® (revumenib) Abstracts Accepted for ASCO 2026, Including an Oral Presentation of Post-Transplant Data https://ml.globenewswire.com/media/399a65b5-bd4f-4ba5-980b-f4d0af9ae6a0/small/syndax-logo-jpg.jpg https://www.dailyhealthcarestlucia.com/article/914161874-akari-therapeutics-reports-breakthrough-preclinical-data-demonstrating-synergistic-activity-of-aktx-101-with-kras-inhibition-in-kras-mutated Daily Healthcare St. Lucia en PressRelease 2026-05-21T21:01:00+00:00 Akari Therapeutics Reports Breakthrough Preclinical Data Demonstrating Synergistic Activity of AKTX-101 with KRAS Inhibition in KRAS-Mutated Pancreatic Cancer Models https://ml.globenewswire.com/media/8d978f50-07a9-40a3-be69-45f51ccd94d9/small/akari-logo-1-jpg.jpg https://www.dailyhealthcarestlucia.com/article/914159763-boehringer-ingelheim-s-oncology-portfolio-shows-strong-promise-across-multiple-cancers-at-asco-2026 Daily Healthcare St. Lucia en PressRelease 2026-05-21T21:00:00+00:00 Boehringer Ingelheim’s oncology portfolio shows strong promise across multiple cancers at ASCO 2026 https://ml-eu.globenewswire.com/media/f121dfae-77e7-4a01-b1ef-6b757767ddab/small/111boehringer-ingelheim-logo-rgb-dark-green-002-png.png https://www.dailyhealthcarestlucia.com/article/914160133-legend-biotech-announces-presentations-at-asco-2026 Daily Healthcare St. Lucia en PressRelease 2026-05-21T21:00:00+00:00 Legend Biotech Announces Presentations at ASCO 2026 https://ml.globenewswire.com/media/d3a680c2-cab6-4eb2-9ed0-7be055f9e180/small/legend-logo-fullcolor-transparent-1-png.png https://www.dailyhealthcarestlucia.com/article/914160307-cardiff-oncology-announces-webcast-to-discuss-updated-phase-2-crdf-004-data-for-onvansertib-in-first-line-ras-mutated-mcrc Daily Healthcare St. Lucia en PressRelease 2026-05-21T21:00:00+00:00 Cardiff Oncology Announces Webcast to Discuss Updated Phase 2 CRDF-004 Data for Onvansertib in First-Line RAS-Mutated mCRC https://ml.globenewswire.com/media/916adb81-8173-4fbe-8095-c284c4f44cd3/small/cardiff-jpg.jpg https://www.dailyhealthcarestlucia.com/article/914160452-olema-oncology-announces-encouraging-initial-clinical-data-from-the-phase-1-study-of-op-3136-a-kat6-inhibitor-at-2026-asco-annual-meeting Daily Healthcare St. Lucia en PressRelease 2026-05-21T21:00:00+00:00 Olema Oncology Announces Encouraging Initial Clinical Data from the Phase 1 Study of OP-3136, a KAT6 Inhibitor, at 2026 ASCO Annual Meeting https://ml.globenewswire.com/media/9c736753-c905-4bd1-ac3a-1444bea84331/small/olema-logo-rgb-png.png https://www.dailyhealthcarestlucia.com/article/914161079-compass-therapeutics-to-present-promising-phase-1-clinical-data-for-ctx-8371-in-patients-with-advanced-malignancies-treated-in-the-post-checkpoint Daily Healthcare St. Lucia en PressRelease 2026-05-21T21:00:00+00:00 Compass Therapeutics to Present Promising Phase 1 Clinical Data for CTX-8371 in Patients with Advanced Malignancies Treated in the Post-Checkpoint Inhibitor Setting at the 2026 ASCO Annual Meeting https://ml.globenewswire.com/media/b8470129-5d30-4368-8074-d77404b65be8/small/compass-logo-rgb-outlines-png.png https://www.dailyhealthcarestlucia.com/article/914161304-ficerafusp-alfa-plus-pembrolizumab-demonstrated-differentiated-three-year-overall-survival-and-deep-responses-driven-by-tgf-inhibition-in-1l-r-m Daily Healthcare St. Lucia en PressRelease 2026-05-21T21:00:00+00:00 Ficerafusp Alfa Plus Pembrolizumab Demonstrated Differentiated Three-Year Overall Survival and Deep Responses Driven by TGF-β Inhibition in 1L R/M HPV-Negative HNSCC https://ml.globenewswire.com/media/fdf5e06f-0748-428a-8f90-b0a1c6f7bdf3/small/bicara-logo-struck-png.png https://www.dailyhealthcarestlucia.com/article/914161429-immuneering-reports-17-3-months-median-overall-survival-in-first-line-metastatic-pancreatic-cancer-patients-treated-with-atebimetinib-plus Daily Healthcare St. Lucia en PressRelease 2026-05-21T21:00:00+00:00 Immuneering Reports 17.3 Months Median Overall Survival in First-Line Metastatic Pancreatic Cancer Patients Treated with Atebimetinib Plus Chemotherapy https://ml.globenewswire.com/media/81d0c83f-ae53-4d6e-9c5e-d6963e02f29d/small/immuneering-logo-cropped-1-jpg.jpg https://www.dailyhealthcarestlucia.com/article/914161439-blossomhill-therapeutics-to-present-preliminary-results-from-phase-1-dose-escalation-backfill-cohorts-in-phase-1-2-solara-trial-of-omni-egfr Daily Healthcare St. Lucia en PressRelease 2026-05-21T21:00:00+00:00 BlossomHill Therapeutics to Present Preliminary Results From Phase 1 Dose Escalation/Backfill Cohorts in Phase 1/2 SOLARA Trial of OMNI-EGFR Inhibitor, BH-30643, in Advanced EGFR-mutant NSCLC at the 2026 ASCO Annual Meeting https://ml.globenewswire.com/media/02f747e9-636d-467e-81f8-d942e9421158/small/blossomhill-vertical-fullcolor-cmyk1-jpg.jpg https://www.dailyhealthcarestlucia.com/article/914161460-rgenta-therapeutics-presents-positive-preliminary-data-from-ongoing-phase-1a-b-clinical-trial-of-rgt-61159-in-patients-with-adenoid-cystic-carcinoma Daily Healthcare St. Lucia en PressRelease 2026-05-21T21:00:00+00:00 Rgenta Therapeutics Presents Positive Preliminary Data from Ongoing Phase 1a/b Clinical Trial of RGT-61159 in Patients with Adenoid Cystic Carcinoma and Colorectal Cancer at the 2026 ASCO Meeting https://ml.globenewswire.com/media/de2f6450-22c4-4c16-b785-04cea917de03/small/rgenta-logo-fullcolor-print-1-png.png https://www.dailyhealthcarestlucia.com/article/914161474-asher-biotherapeutics-announces-two-presentations-at-the-asco-2026-annual-meeting-highlighting-clinical-progress-across-its-cd8-targeted-cytokine Daily Healthcare St. Lucia en PressRelease 2026-05-21T21:00:00+00:00 Asher Biotherapeutics Announces Two Presentations at the ASCO 2026 Annual Meeting Highlighting Clinical Progress Across Its CD8-Targeted Cytokine Pipeline https://ml.globenewswire.com/media/3b2f30c8-cc67-45e5-a0d5-27b5e2c43de8/small/asher-bio-logo-rgb-large-png.png https://www.dailyhealthcarestlucia.com/article/914162207-hibercell-to-present-preliminary-results-from-the-phase-1b-trial-of-gcn2-activator-hc-7366-when-combined-with-welireg-belzutifan-for-the-treatment Daily Healthcare St. Lucia en PressRelease 2026-05-21T21:00:00+00:00 HiberCell to Present Preliminary Results from the Phase 1b Trial of GCN2 Activator HC-7366 when Combined with WELIREG® (belzutifan) for the Treatment of Late-Line Clear Cell Renal Cell Carcinoma (ccRCC) at the Upcoming 2026 ASCO Annual Meeting https://ml.globenewswire.com/media/d168805a-8691-40f2-abcf-fb63a607f112/small/hybercell-jpg.jpg https://www.dailyhealthcarestlucia.com/article/914162080-seer-board-of-directors-unanimously-rejects-further-revised-unsolicited-proposal-from-radoff-jec-group Daily Healthcare St. Lucia en PressRelease 2026-05-21T20:38:38+00:00 Seer Board of Directors Unanimously Rejects Further Revised Unsolicited Proposal from Radoff-JEC Group https://ml.globenewswire.com/media/a5aaadad-13a1-4dbd-8ba2-d57cbbc610fb/small/seer-brandmark-rgb-full-jpg.jpg https://www.dailyhealthcarestlucia.com/article/914131867-mental-health-care-in-utah-gets-major-boost-with-new-behavioral-health-center-at-intermountain-health-alta-view-hospital Daily Healthcare St. Lucia en PressRelease 2026-05-21T20:30:03+00:00 Mental Health Care in Utah Gets Major Boost with New Behavioral Health Center at Intermountain Health Alta View Hospital https://ml.globenewswire.com/media/M2RhNGQ2MzYtOGQxZC00Njg5LTkzYWMtOTYzMzFmZGUyYThiLTEyNjkxMjYtMjAyNi0wNS0yMS1lbg==/tiny/Intermountain-Health.png https://www.dailyhealthcarestlucia.com/article/914131634-adaptive-biotechnologies-to-participate-in-upcoming-investor-conferences Daily Healthcare St. Lucia en PressRelease 2026-05-21T20:17:30+00:00 Adaptive Biotechnologies to Participate in Upcoming Investor Conferences https://ml.globenewswire.com/media/6c319974-0bac-45f1-83d9-ae9987dfdf44/small/adpt-new-logo-jpg.jpg https://www.dailyhealthcarestlucia.com/article/914128710-first-tracks-biotherapeutics-announces-participation-in-upcoming-investor-conferences Daily Healthcare St. Lucia en PressRelease 2026-05-21T20:15:00+00:00 First Tracks Biotherapeutics Announces Participation in Upcoming Investor Conferences https://ml.globenewswire.com/media/7165e7cf-d98b-4a0f-90f3-3cd8f3a6b320/small/ftb-logo-png.png https://www.dailyhealthcarestlucia.com/article/914131141-lunavelle-sleep-patches-claims-evaluated-most-effective-melatonin-free-patches-for-deeper-rest-with-time-tested-ingredients-proven-to-work Daily Healthcare St. Lucia en PressRelease 2026-05-21T20:05:36+00:00 Lunavelle Sleep Patches Claims Evaluated: Most Effective Melatonin-Free Patches for Deeper Rest with Time-Tested Ingredients Proven To Work https://zingfast.com/wp-content/uploads/2026/05/Lunavelle-Sleep-Patches.jpg https://www.dailyhealthcarestlucia.com/article/914127952-pacbio-to-participate-in-the-jefferies-global-healthcare-conference Daily Healthcare St. Lucia en PressRelease 2026-05-21T20:05:00+00:00 PacBio to Participate in the Jefferies Global Healthcare Conference  https://ml.globenewswire.com/media/f408d681-e68c-4113-a7cd-be24486deefc/small/logo-centered-440x386-png.png https://www.dailyhealthcarestlucia.com/article/914128623-outset-medical-reports-inducement-grant-under-nasdaq-listing-rule-5635-c-4 Daily Healthcare St. Lucia en PressRelease 2026-05-21T20:05:00+00:00 Outset Medical Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) https://ml.globenewswire.com/media/28778c78-03f1-4b17-9c13-3cc578c924dc/small/outset-id-orangegrey-png.png https://www.dailyhealthcarestlucia.com/article/914128819-revolution-medicines-to-host-investor-conference-call-on-positive-rasolute-302-results-following-2026-asco-presentation Daily Healthcare St. Lucia en PressRelease 2026-05-21T20:05:00+00:00 Revolution Medicines to Host Investor Conference Call on Positive RASolute 302 Results Following 2026 ASCO Presentation https://ml.globenewswire.com/media/771b34d9-586d-435a-a976-ab0ab847571b/small/balanced-green-primary-logo-medium-1000px-png.png https://www.dailyhealthcarestlucia.com/article/914128898-madrigal-pharmaceuticals-announces-grants-of-inducement-awards-under-nasdaq-listing-rule-5635-c-4 Daily Healthcare St. Lucia en PressRelease 2026-05-21T20:05:00+00:00 Madrigal Pharmaceuticals Announces Grants of Inducement Awards under Nasdaq Listing Rule 5635(c)(4) https://ml.globenewswire.com/media/8fec8de1-1a2e-4f6c-a679-fc43002276ba/small/madrigal-logo-jpg.jpg https://www.dailyhealthcarestlucia.com/article/914129096-camp4-therapeutics-announces-inducement-grant-under-nasdaq-listing-rule-5635-c-4 Daily Healthcare St. Lucia en PressRelease 2026-05-21T20:05:00+00:00 CAMP4 Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) https://ml.globenewswire.com/media/72048fc6-0a8d-4ed2-9be8-ec0ee0afd8ba/small/cmp4-21-logo-full-color-jpg.jpg https://www.dailyhealthcarestlucia.com/article/914129173-cue-biopharma-to-present-at-the-2026-jefferies-global-healthcare-conference Daily Healthcare St. Lucia en PressRelease 2026-05-21T20:05:00+00:00 Cue Biopharma to Present at the 2026 Jefferies Global Healthcare Conference https://ml.globenewswire.com/media/10541379-34cc-4869-a26f-fd99feead42a/small/cue-bio-brand-strategy-graphics-jpg.jpg https://www.dailyhealthcarestlucia.com/article/914130503-beta-bionics-updates-commercialization-timeline-expectations-for-mint-its-patch-pump-in-development Daily Healthcare St. Lucia en PressRelease 2026-05-21T20:04:00+00:00 Beta Bionics Updates Commercialization Timeline Expectations for Mint™, its Patch Pump in Development https://ml.globenewswire.com/media/dd9f136d-aea8-46b4-8bfa-63568d4bc933/medium/mint-by-beta-bionics.jpg https://www.dailyhealthcarestlucia.com/article/914130694-nervgen-announces-proposed-public-offering-of-securities Daily Healthcare St. Lucia en PressRelease 2026-05-21T20:01:00+00:00 NervGen Announces Proposed Public Offering of Securities https://ml.globenewswire.com/media/bb42d0ef-06b6-4b90-8389-ca991092aa37/small/nervgen-logo-updated-globenewswire-png.png https://www.dailyhealthcarestlucia.com/article/914127350-inventiva-to-present-at-2026-jefferies-global-healthcare-conference Daily Healthcare St. Lucia en PressRelease 2026-05-21T20:00:00+00:00 Inventiva to Present at 2026 Jefferies Global Healthcare Conference   https://ml-eu.globenewswire.com/media/d96e203b-8941-46c7-888a-508900ab9a8b/small/logo-iva-jpg.jpg https://www.dailyhealthcarestlucia.com/article/914127354-inventiva-pr-sentera-lors-de-la-2026-jefferies-global-healthcare-conference Daily Healthcare St. Lucia en PressRelease 2026-05-21T20:00:00+00:00 Inventiva présentera lors de la 2026 Jefferies Global Healthcare Conference https://ml-eu.globenewswire.com/media/d96e203b-8941-46c7-888a-508900ab9a8b/small/ https://www.dailyhealthcarestlucia.com/article/914127557-oddifact-obtient-la-d-signation-m-dicament-orphelin-de-la-commission-europ-enne-pour-l-infliximab-dans-la-maladie-de-kawasaki Daily Healthcare St. Lucia en PressRelease 2026-05-21T18:50:22+00:00 ODDIFACT obtient la désignation médicament orphelin de la Commission Européenne pour l’infliximab dans la maladie de Kawasaki https://ml-eu.globenewswire.com/media/e678baea-021e-47f5-9676-4ef415772a73/small/ https://www.dailyhealthcarestlucia.com/article/914127755-oddifact-receives-european-commission-orphan-drug-designation-for-infliximab-in-kawasaki-disease Daily Healthcare St. Lucia en PressRelease 2026-05-21T18:50:22+00:00 ODDIFACT Receives European Commission Orphan Drug Designation for Infliximab in Kawasaki Disease https://ml-eu.globenewswire.com/media/e678baea-021e-47f5-9676-4ef415772a73/small/logo-oddifact-png.png https://www.dailyhealthcarestlucia.com/article/914098116-bulkglp-announces-dual-tier-quality-verification-protocol-for-global-supply-of-analytical-reference-materials Daily Healthcare St. Lucia en PressRelease 2026-05-21T17:51:44+00:00 BulkGLP Announces Dual-Tier Quality Verification Protocol for Global Supply of Analytical Reference Materials https://ml.globenewswire.com/media/d8909950-3310-4178-9552-aa9f02c08d58/medium/bulkglp-logo.png https://www.dailyhealthcarestlucia.com/article/914097996-nmdp-gala-in-new-york-city-raises-record-breaking-660-000-enabling-more-patients-to-receive-life-saving-cell-therapy Daily Healthcare St. Lucia en PressRelease 2026-05-21T17:27:28+00:00 NMDP Gala in New York City Raises Record-Breaking $660,000 Enabling More Patients to Receive Life-Saving Cell Therapy https://ml.globenewswire.com/media/07439704-ea73-4f29-9900-95a8261e9c45/medium/nmdp-gala-nyc-2026.jpg https://www.dailyhealthcarestlucia.com/article/914097786-the-joint-corp-announces-milind-pant-elected-as-director Daily Healthcare St. Lucia en PressRelease 2026-05-21T17:15:42+00:00 The Joint Corp. Announces Milind Pant Elected as Director https://ml.globenewswire.com/media/06d3923c-3eba-4556-9ea8-8ae021e5d624/medium/milind-pant.jpg https://www.dailyhealthcarestlucia.com/article/914095176-iqity-and-sightpath-medical-partner-to-deliver-advanced-ophthalmic-technology-to-surgeons-nationwide Daily Healthcare St. Lucia en PressRelease 2026-05-21T17:00:00+00:00 IQity and Sightpath Medical Partner to Deliver Advanced Ophthalmic Technology to Surgeons Nationwide https://ml.globenewswire.com/media/3c8b4c05-f739-4d3f-aec6-fd14a2f30477/small/iqity-logo-colour-hr-png.png https://www.dailyhealthcarestlucia.com/article/914095714-seven-arrows-recovery-expands-public-education-efforts-around-forward-facing-nervous-system-centered-addiction-treatment Daily Healthcare St. Lucia en PressRelease 2026-05-21T16:50:00+00:00 Seven Arrows Recovery Expands Public Education Efforts Around Forward Facing, Nervous System Centered Addiction Treatment https://pressranger.s3.us-west-1.amazonaws.com/3295657/SCR-20260519-morx.jpeg https://www.dailyhealthcarestlucia.com/article/914095441-paul-cobbo-to-head-leading-brisbane-ndis-provider-orange-plan-management Daily Healthcare St. Lucia en PressRelease 2026-05-21T16:43:00+00:00 Paul Cobbo to head leading Brisbane NDIS provider Orange Plan Management https://ml.globenewswire.com/media/7fd78358-b451-4206-b2da-4e494d7951ac/small/orange-plan-management-logo.png https://www.dailyhealthcarestlucia.com/article/914093724-the-european-medicines-agency-accepts-teva-s-marketing-authorization-application-for-olanzapine-long-acting-injectable-tev-749-for-the-treatment-of Daily Healthcare St. Lucia en PressRelease 2026-05-21T16:30:00+00:00 The European Medicines Agency Accepts Teva’s Marketing Authorization Application for Olanzapine Long-Acting Injectable (TEV-‘749) for the Treatment of Schizophrenia in Adults https://ml-eu.globenewswire.com/media/c2001734-949b-4cc2-8021-b4b64eda1f13/small/teva-rgb-jpeg-jpg.jpg https://www.dailyhealthcarestlucia.com/article/914097382-new-study-reveals-major-gaps-in-follow-up-care-for-patients-with-heart-failure Daily Healthcare St. Lucia en PressRelease 2026-05-21T16:22:25+00:00 New study reveals major gaps in follow-up care for patients with heart failure https://ml.globenewswire.com/media/ZWM2NWEwM2QtMGU1Yi00N2NjLWFiMzAtODJkZWRmOGYwMjU4LTEyNzUzNzQtMjAyNi0wNS0yMS1lbg==/tiny/Truveta.png https://www.dailyhealthcarestlucia.com/article/914097658-tevogen-signs-letter-of-intent-to-evaluate-potential-acquisition-of-a-management-services-organization Daily Healthcare St. Lucia en PressRelease 2026-05-21T16:15:00+00:00 Tevogen Signs Letter of Intent to Evaluate Potential Acquisition of a Management Services Organization https://ml.globenewswire.com/media/fc68b89a-e411-4311-a10a-2d1ea9bf5122/medium/tevogen-signs-letter-of-intent-to-evaluate-potential-acquisi.png https://www.dailyhealthcarestlucia.com/article/914097188-corrected-distalmotion-accelerates-us-commercial-momentum-in-ambulatory-surgery-centers Daily Healthcare St. Lucia en PressRelease 2026-05-21T16:05:17+00:00 CORRECTED: Distalmotion Accelerates US Commercial Momentum in Ambulatory Surgery Centers https://ml.globenewswire.com/media/MDY5ZGVlYmQtNWQ0ZS00MzM2LTljYzEtYmE5NzZmN2FkZGNmLTEyNzYyNjYtMjAyNi0wNS0yMS1lbg==/tiny/Distalmotion.png https://www.dailyhealthcarestlucia.com/article/914093160-genfit-information-financi-re-du-premier-trimestre-2026-et-point-sur-les-activit-s-de-la-soci-t Daily Healthcare St. Lucia en PressRelease 2026-05-21T16:00:00+00:00 GENFIT : Information financière du premier trimestre 2026 et point sur les activités de la Société   https://ml-eu.globenewswire.com/media/YWZlNmEyNzMtMWZmYi00YzM2LWEyYTMtMjY4ZDhhYTE1NWMzLTEwMTEyNjgtMjAyNi0wNS0yMS1mcg==/tiny/GENFIT-S-A-.png https://www.dailyhealthcarestlucia.com/article/914093410-genfit-reports-first-quarter-2026-financial-information-and-provides-a-corporate-update Daily Healthcare St. Lucia en PressRelease 2026-05-21T16:00:00+00:00 GENFIT Reports First Quarter 2026 Financial Information and Provides a Corporate Update https://ml-eu.globenewswire.com/media/YWZlNmEyNzMtMWZmYi00YzM2LWEyYTMtMjY4ZDhhYTE1NWMzLTEwMTEyNjgtMjAyNi0wNS0yMS1lbg==/tiny/GENFIT-S-A-.png https://www.dailyhealthcarestlucia.com/article/914065564-tiziana-fully-enrolls-its-phase-2-placebo-controlled-multiple-sclerosis-trial Daily Healthcare St. Lucia en PressRelease 2026-05-21T15:00:00+00:00 Tiziana Fully Enrolls its Phase 2 Placebo Controlled Multiple Sclerosis Trial https://ml.globenewswire.com/media/991c340c-a083-4bcb-ad41-e7eea83f6f97/small/tiziana-logo-png.png https://www.dailyhealthcarestlucia.com/article/914066018-nanobiotix-announces-pricing-of-oversubscribed-85m-global-offering Daily Healthcare St. Lucia en PressRelease 2026-05-21T14:57:23+00:00 Nanobiotix Announces Pricing of Oversubscribed €85m Global Offering https://ml.globenewswire.com/media/36fb7b98-27d7-46cb-b989-fa31626657b8/small/nanobiotix-logo-jpg.jpg https://www.dailyhealthcarestlucia.com/article/914064324-digital-health-market-projected-to-reach-usd-573-5-billion-by-2030-marketsandmarkets Daily Healthcare St. Lucia en PressRelease 2026-05-21T14:30:00+00:00 Digital Health Market Projected to Reach USD 573.5 Billion by 2030 | MarketsandMarkets™ https://ml.globenewswire.com/media/afcc5182-4ae0-43a8-a965-4351d590b7ed/small/mnm-logo-tm-jpg-jpg.JPG https://www.dailyhealthcarestlucia.com/article/914064932-carrington-college-invites-community-to-explore-healthcare-careers-at-open-house-on-may-28 Daily Healthcare St. Lucia en PressRelease 2026-05-21T14:09:00+00:00 Carrington College Invites Community to Explore Healthcare Careers at Open House on May 28 https://ml.globenewswire.com/media/ZDg2ODhjYzUtY2RhNy00YWIxLWI0ODAtMTQwMjBjODQ0NDRmLTUwMDE0OTgyNy0yMDI2LTA1LTIxLWVu/tiny/Carrington-College.png https://www.dailyhealthcarestlucia.com/article/914064342-medical-adhesives-market-worth-14-90-billion-in-2031-at-a-cagr-of-5-5-says-marketsandmarkets Daily Healthcare St. Lucia en PressRelease 2026-05-21T14:03:00+00:00 Medical Adhesives Market worth $14.90 billion in 2031, at a CAGR of 5.5%, says MarketsandMarkets™ https://ml.globenewswire.com/media/afcc5182-4ae0-43a8-a965-4351d590b7ed/small/mnm-logo-tm-jpg-jpg.JPG https://www.dailyhealthcarestlucia.com/article/914065790-communities-come-together-for-national-deafblind-awareness-month-2026 Daily Healthcare St. Lucia en PressRelease 2026-05-21T14:01:57+00:00 Communities Come Together for National Deafblind Awareness Month 2026 https://ml.globenewswire.com/media/YjkwY2Q4MGUtMjNjOC00NDljLWI5NzEtOTY5Mjk3MzQzODQ0LTEyNzEyMDItMjAyNi0wNS0yMS1lbg==/tiny/DeafBlind-Ontario-Services.png https://www.dailyhealthcarestlucia.com/article/914064293-medicana-strengthens-its-international-sports-presence-through-expanded-healthcare-partnership-with-fenerbah-e Daily Healthcare St. Lucia en PressRelease 2026-05-21T14:00:00+00:00 Medicana Strengthens Its International Sports Presence Through Expanded Healthcare Partnership with Fenerbahçe https://ml-eu.globenewswire.com/media/7cc67616-c47f-41c0-90af-817946c3900d/medium/medicana-national-teams-health-sponsor-press-conference.jpeg https://www.dailyhealthcarestlucia.com/article/914064365-nsk-dental-achieves-back-to-back-top-ratings-in-dental-product-shopper-peer-evaluations Daily Healthcare St. Lucia en PressRelease 2026-05-21T14:00:00+00:00 NSK Dental Achieves Back-to-Back Top Ratings in Dental Product Shopper Peer Evaluations https://pressranger.s3.us-west-1.amazonaws.com/3295727/1746737398NSK_Z99L_Web-images_ENG_Z99L10.jpg-new-NSK_Z99L_Web-images_ENG_Z99L10.png https://www.dailyhealthcarestlucia.com/article/914065681-for-the-assist-haleon-canada-launches-national-campaign-with-canada-soccer-to-celebrate-the-small-health-supports-behind-canadian-wellbeing Daily Healthcare St. Lucia en PressRelease 2026-05-21T13:59:40+00:00 ‘For The Assist’: Haleon Canada launches national campaign with Canada Soccer to celebrate the small health supports behind Canadian wellbeing https://ml.globenewswire.com/media/60159111-f44a-45eb-b828-f73d2fc6eba3/medium/haleon-canada-launches-for-the-assist-campaign.png https://www.dailyhealthcarestlucia.com/article/914065678-hcw-biologics-inc-announces-pricing-of-approximately-4-0-million-private-placement-offering-at-the-market-under-nasdaq-rules Daily Healthcare St. Lucia en PressRelease 2026-05-21T13:53:05+00:00 HCW Biologics Inc. Announces Pricing of Approximately $4.0 Million Private Placement Offering At-the-Market Under Nasdaq Rules https://ml.globenewswire.com/media/5689edc3-6997-43a0-a20c-b34dc5f99b0f/small/hcw-logo-full-color-600x-jpeg-2-jpg.jpg https://www.dailyhealthcarestlucia.com/article/914065157-nanobiotix-announces-trading-resumption-of-its-ordinary-shares-on-euronext-paris Daily Healthcare St. Lucia en PressRelease 2026-05-21T13:30:00+00:00 Nanobiotix Announces Trading Resumption of Its Ordinary Shares on Euronext Paris https://ml.globenewswire.com/media/36fb7b98-27d7-46cb-b989-fa31626657b8/small/nanobiotix-logo-jpg.jpg https://www.dailyhealthcarestlucia.com/article/914065165-nanobiotix-annonce-la-reprise-des-n-gociations-de-ses-actions-ordinaires-sur-euronext-paris Daily Healthcare St. Lucia en PressRelease 2026-05-21T13:30:00+00:00 Nanobiotix annonce la reprise des négociations de ses actions ordinaires sur Euronext Paris https://ml.globenewswire.com/media/36fb7b98-27d7-46cb-b989-fa31626657b8/small/nanobiotix-logo-jpg.jpg https://www.dailyhealthcarestlucia.com/article/914064868-intuitive-announces-innovations-to-advance-quintuple-aim Daily Healthcare St. Lucia en PressRelease 2026-05-21T13:15:00+00:00 Intuitive Announces Innovations to Advance Quintuple Aim https://ml.globenewswire.com/media/db89f2a9-76ed-4743-84d3-a7ac75605b6c/small/logo-jpg.jpg https://www.dailyhealthcarestlucia.com/article/914065276-biofrontera-inc-to-participate-in-the-lytham-partners-spring-2026-investor-conference-on-may-28-2026 Daily Healthcare St. Lucia en PressRelease 2026-05-21T13:15:00+00:00 Biofrontera Inc. to Participate in the Lytham Partners Spring 2026 Investor Conference on May 28, 2026 https://ml.globenewswire.com/media/4af5197e-340e-4307-892b-382a1d29ae45/small/logo-png.png https://www.dailyhealthcarestlucia.com/article/914064376-distalmotion-accelerates-us-commercial-momentum-in-ambulatory-surgery-centers Daily Healthcare St. Lucia en PressRelease 2026-05-21T13:00:00+00:00 Distalmotion Accelerates US Commercial Momentum in Ambulatory Surgery Centers https://ml.globenewswire.com/media/OTQ3ZGMzZGYtYTJlYS00NjJkLWI2YTgtYzc5M2FjYjI3ZmQ4LTEyNzYyNjYtMjAyNi0wNS0yMS1lbg==/tiny/Distalmotion.png https://www.dailyhealthcarestlucia.com/article/914065016-zangmeister-cancer-center-becomes-affiliate-of-ohio-state-university-s-james-cancer-network-expanding-access-to-exceptional-community-based-cancer Daily Healthcare St. Lucia en PressRelease 2026-05-21T13:00:00+00:00 Zangmeister Cancer Center Becomes Affiliate of Ohio State University’s James Cancer Network, Expanding Access to Exceptional Community-Based Cancer Care Across Central Ohio https://ml.globenewswire.com/media/0fe4c56b-ab29-42a5-828f-6d4a488b67b8/medium/zangmeister-cancer-center-becomes-affiliate-of-ohio-state-un.png https://www.dailyhealthcarestlucia.com/article/914065570-hanmi-pharmaceutical-organon Daily Healthcare St. Lucia en PressRelease 2026-05-21T12:50:30+00:00 Hanmi Pharmaceutical تتعاون مع Organon لتصدير علاجات مركبة إلى جنوب شرق آسيا https://ml.globenewswire.com/media/526a18fe-e048-4862-91e5-0a6effeaf8ab/small/hanmi-pharmaceutical-logo-jpg.jpg https://www.dailyhealthcarestlucia.com/article/914065462-5-000-swedes-sign-on-to-protect-the-swedish-success-story Daily Healthcare St. Lucia en PressRelease 2026-05-21T12:37:00+00:00 5,000 Swedes sign on to protect the Swedish success story https://ml.globenewswire.com/media/32408c88-e4d9-4ef5-bceb-b302b3c2ab3f/small/den-svenska-succen-logo-png.png https://www.dailyhealthcarestlucia.com/article/914065480-5-000-svenskar-har-skrivit-under-f-r-att-skydda-den-svenska-succ-n Daily Healthcare St. Lucia en PressRelease 2026-05-21T12:37:00+00:00 5 000 svenskar har skrivit under för att skydda den svenska succén https://ml.globenewswire.com/media/32408c88-e4d9-4ef5-bceb-b302b3c2ab3f/small/den-svenska-succen-logo-png.png https://www.dailyhealthcarestlucia.com/article/914064876-nexalin-technology-secures-key-neurostimulation-legislative-provision-commends-u-s-house-passed-report-language-expanding-non-invasive-deep-brain Daily Healthcare St. Lucia en PressRelease 2026-05-21T12:30:00+00:00 Nexalin Technology Secures Key Neurostimulation Legislative Provision & Commends U.S. House-Passed Report Language Expanding Non-Invasive Deep Brain Neurostimulation Research at the Department of Veterans Affairs for Traumatic Brain Injury https://ml.globenewswire.com/media/7f481b55-16b6-4c8a-8356-30d54079a605/small/nexalin-jpg.jpg https://www.dailyhealthcarestlucia.com/article/914065242-newgenivf-announces-strategic-investment-agreement-with-tech-veteran-andy-cheung-led-k25-ai-an-ai-powered-live-streaming-prediction-market-at-us-100 Daily Healthcare St. Lucia en PressRelease 2026-05-21T12:30:00+00:00 NewGenIVF Announces Strategic Investment Agreement with Tech Veteran Andy Cheung-Led K25.ai, an AI-Powered Live-Streaming Prediction Market, at US$100 Million Valuation https://ml.globenewswire.com/media/MzI3YTk4NzktNzQ0Mi00YzAzLWFlMGUtMTQyYTI4MGE3OTEwLTEyOTcwMTEtMjAyNi0wNS0yMS1lbg==/tiny/NewGenIvf-Limited.png https://www.dailyhealthcarestlucia.com/article/914065274-akari-therapeutics-announces-5-5-million-private-placement-offering Daily Healthcare St. Lucia en PressRelease 2026-05-21T12:30:00+00:00 Akari Therapeutics Announces $5.5 Million Private Placement Offering https://ml.globenewswire.com/media/8d978f50-07a9-40a3-be69-45f51ccd94d9/small/akari-logo-1-jpg.jpg https://www.dailyhealthcarestlucia.com/article/914040905-iovance-biotherapeutics-to-present-at-upcoming-conference Daily Healthcare St. Lucia en PressRelease 2026-05-21T12:05:00+00:00 Iovance Biotherapeutics to Present at Upcoming Conference https://ml.globenewswire.com/media/d0986bd6-4603-4e31-8ed1-f23b3e123605/small/iovance-jpg.jpg https://www.dailyhealthcarestlucia.com/article/914041205-liminatus-pharma-announces-proposed-merger-with-innocsai-to-expand-oncology-cell-therapy-pipeline Daily Healthcare St. Lucia en PressRelease 2026-05-21T12:04:00+00:00 Liminatus Pharma Announces Proposed Merger with InnocsAI to Expand Oncology Cell Therapy Pipeline https://ml.globenewswire.com/media/9ad52a99-f6dd-4ecb-8aa0-15713a0e8788/small/picture1-png.png https://www.dailyhealthcarestlucia.com/article/914040751-siam-announces-dr-magnus-fontes-as-2026-i-e-block-community-lecture-speaker Daily Healthcare St. Lucia en PressRelease 2026-05-21T12:00:00+00:00 SIAM Announces Dr. Magnus Fontes as 2026 I. E. Block Community Lecture Speaker https://ml.globenewswire.com/media/ZTc3ZTllZmEtOWZlYi00NjgzLWFhNTItYjA3ZWZkMjUwOGQ1LTExMDEyMzMtMjAyNi0wNS0yMS1lbg==/tiny/Society-for-Industrial-and-App.png https://www.dailyhealthcarestlucia.com/article/914040803-tvardi-therapeutics-to-participate-in-upcoming-investor-events Daily Healthcare St. Lucia en PressRelease 2026-05-21T12:00:00+00:00 Tvardi Therapeutics to Participate in Upcoming Investor Events https://ml.globenewswire.com/media/65859e40-e7db-474e-b604-78033b160f6b/small/tvardi-therapeutics-logo-1200-jpg.jpg https://www.dailyhealthcarestlucia.com/article/914040806-spyglass-pharma-to-participate-in-upcoming-investor-conferences Daily Healthcare St. Lucia en PressRelease 2026-05-21T12:00:00+00:00 SpyGlass Pharma to Participate in Upcoming Investor Conferences https://ml.globenewswire.com/media/fe0fc2c2-1623-4d3f-94bb-41782201a1e6/small/spyglass-pharma-logo-long-png.png https://www.dailyhealthcarestlucia.com/article/914040962-cytomx-therapeutics-to-present-at-upcoming-june-investor-conferences Daily Healthcare St. Lucia en PressRelease 2026-05-21T12:00:00+00:00 CytomX Therapeutics to Present at Upcoming June Investor Conferences https://ml.globenewswire.com/media/c252869d-a4c1-4e56-88e8-d80b85d20c35/small/cytomx-logo-jpg.jpg https://www.dailyhealthcarestlucia.com/article/914040994-new-study-shows-significant-improvement-in-cellulite-and-skin-laxity-with-advanced-minimally-invasive-treatment-utilizing-av-li-and-renuvion Daily Healthcare St. Lucia en PressRelease 2026-05-21T12:00:00+00:00 New Study Shows Significant Improvement in Cellulite and Skin Laxity with Advanced Minimally Invasive Treatment Utilizing Avéli® and Renuvion® https://ml.globenewswire.com/media/aa0687d3-ab28-4615-b1e7-ef6c6e2a5541/small/apyx-medical-logo-jpg.jpg https://www.dailyhealthcarestlucia.com/article/914041019-avalyn-announces-additional-long-term-data-on-ap01-inhaled-pirfenidone-for-the-treatment-of-pulmonary-fibrosis-to-be-presented-at-the-european Daily Healthcare St. Lucia en PressRelease 2026-05-21T12:00:00+00:00 Avalyn Announces Additional Long-term Data on AP01, Inhaled Pirfenidone, for the Treatment of Pulmonary Fibrosis to be Presented at the European Alliance of Associations for Rheumatology 2026 https://ml.globenewswire.com/media/84d7bff4-ce17-433b-8c71-aa20c30f9f43/small/avalyn-logo-final-png.png https://www.dailyhealthcarestlucia.com/article/914041067-genvor-appoints-donald-kalkofen-as-chief-financial-officer Daily Healthcare St. Lucia en PressRelease 2026-05-21T12:00:00+00:00 Genvor Appoints Donald Kalkofen as Chief Financial Officer https://ml.globenewswire.com/media/8533fef9-aa8f-43c5-9088-39ab06147641/small/43464-png.png https://www.dailyhealthcarestlucia.com/article/914041109-biocardia-announces-cardiamp-chronic-myocardial-ischemia-trial-results-presented-at-europcr-showed-durable-improvements-in-exercise-tolerance-with Daily Healthcare St. Lucia en PressRelease 2026-05-21T12:00:00+00:00 BioCardia Announces CardiAMP Chronic Myocardial Ischemia Trial Results Presented at EuroPCR Showed Durable Improvements in Exercise Tolerance with Reduced Angina Frequency https://ml.globenewswire.com/media/4641bb53-4913-4654-a337-79383a5c7ab9/small/biocardia-final-logo-2016-jpeg-jpg.jpg https://www.dailyhealthcarestlucia.com/article/914041191-kal-o-sponsors-may-contain-docudrama-premieres-highlighting-the-realities-of-food-allergy-and-anaphylaxis Daily Healthcare St. Lucia en PressRelease 2026-05-21T12:00:00+00:00 Kaléo Sponsors May Contain Docudrama Premieres Highlighting the Realities of Food Allergy and Anaphylaxis https://ml.globenewswire.com/media/MmE0ZTRhYTYtMGQyNC00MzhmLWI3MTItOWYxMThmMmFkMzdjLTUwMDE2MTM4Ni0yMDI2LTA1LTIxLWVu/tiny/Kal-o.png https://www.dailyhealthcarestlucia.com/article/914041296-flyte-activates-high-frequency-memorial-day-weekend-flight-network-to-capture-surging-northeast-demand Daily Healthcare St. Lucia en PressRelease 2026-05-21T12:00:00+00:00 FLYTE ACTIVATES HIGH-FREQUENCY MEMORIAL DAY WEEKEND FLIGHT NETWORK TO CAPTURE SURGING NORTHEAST DEMAND https://ml.globenewswire.com/media/cb9f10dc-be78-4c7c-a235-81bfdd77f03c/small/catheterlogo-jpg.jpg https://www.dailyhealthcarestlucia.com/article/914041452-brain-cancer-canada-awards-the-dwayne-andrews-glioblastoma-research-grant-to-tackle-one-of-the-most-aggressive-brain-tumours-and-unlock-immunotherapy Daily Healthcare St. Lucia en PressRelease 2026-05-21T12:00:00+00:00 Brain Cancer Canada Awards The Dwayne Andrews Glioblastoma Research Grant to Tackle One of the Most Aggressive Brain Tumours and Unlock Immunotherapy Breakthroughs for Young Patients https://ml.globenewswire.com/media/78a73b7f-a470-42a5-9976-aa425939a68b/small/bcc-logo-2024-png.png https://www.dailyhealthcarestlucia.com/article/914041503-micron-biomedical-celebrates-the-grand-opening-of-its-commercial-scale-manufacturing-site-in-georgia Daily Healthcare St. Lucia en PressRelease 2026-05-21T12:00:00+00:00 Micron Biomedical Celebrates the Grand Opening of Its Commercial-Scale Manufacturing Site in Georgia https://ml.globenewswire.com/media/31153de2-caed-4aa2-b291-ebeed2652b70/medium/the-opening-of-the-first-commercial-scale-manufacturing-site.jpg https://www.dailyhealthcarestlucia.com/article/914041698-qtrex-in-advanced-discussions-with-top-five-global-quantum-computing-company-regarding-strategic-collaboration Daily Healthcare St. Lucia en PressRelease 2026-05-21T12:00:00+00:00 QTREX in Advanced Discussions with Top-Five Global Quantum Computing Company Regarding Strategic Collaboration https://ml.globenewswire.com/media/418aae9b-ab46-4b61-a649-88b2eef4fc28/small/72a8c93a11446a0369bf7fb191b9562d-png.png https://www.dailyhealthcarestlucia.com/article/914041997-corbus-pharmaceuticals-announces-the-appointment-of-nishant-saxena-as-chief-business-officer-and-schedules-a-pre-2026-asco-crb-701-data-conference Daily Healthcare St. Lucia en PressRelease 2026-05-21T12:00:00+00:00 Corbus Pharmaceuticals Announces the Appointment of Nishant Saxena as Chief Business Officer and Schedules a Pre-2026 ASCO CRB-701 Data Conference Call https://ml.globenewswire.com/media/49d930e7-3294-4713-aaee-aef2b1829e3c/medium/nishant-saxena.jpg https://www.dailyhealthcarestlucia.com/article/914040604-edap-focal-one-to-present-at-jefferies-2026-global-healthcare-conference Daily Healthcare St. Lucia en PressRelease 2026-05-21T11:30:00+00:00 EDAP | Focal One to Present at Jefferies 2026 Global Healthcare Conference https://ml-eu.globenewswire.com/media/ded19329-9645-4860-ac2d-bf3e2422b649/small/focalone-square-logo-drkblue-web-400-1-png.png https://www.dailyhealthcarestlucia.com/article/914040648-antag-therapeutics-appoints-obesity-treatment-pioneer-philip-just-larsen-as-chief-executive-officer Daily Healthcare St. Lucia en PressRelease 2026-05-21T11:30:00+00:00 Antag Therapeutics appoints obesity treatment pioneer Philip Just Larsen as Chief Executive Officer https://ml-eu.globenewswire.com/media/5001e437-9bc0-482c-9bee-3be9c9f71505/small/antag-logo-black-rgb-jpg.jpg https://www.dailyhealthcarestlucia.com/article/914041060-cognition-therapeutics-completes-meeting-with-fda-for-zervimesine-ct1812-in-dementia-with-lewy-bodies-with-psychosis Daily Healthcare St. Lucia en PressRelease 2026-05-21T11:30:00+00:00 Cognition Therapeutics Completes Meeting with FDA for Zervimesine (CT1812) in Dementia with Lewy Bodies with Psychosis https://ml.globenewswire.com/media/a14fd627-7ccb-45e2-95fe-792bbfb83231/small/2020-0227-cognition-logo-for-gnw-png.png https://www.dailyhealthcarestlucia.com/article/914041192-palvella-therapeutics-named-healthcare-life-sciences-company-of-the-year-at-the-philadelphia-alliance-for-capital-and-technologies-pact-ecosystem Daily Healthcare St. Lucia en PressRelease 2026-05-21T11:30:00+00:00 Palvella Therapeutics Named Healthcare & Life Sciences Company of the Year at the Philadelphia Alliance for Capital and Technologies (PACT) Ecosystem Awards https://ml.globenewswire.com/media/83fd569b-5e6c-46ad-882a-6430f8ab755a/small/palvella-2025-logo-new-jpg.jpg https://www.dailyhealthcarestlucia.com/article/914041141-lifecore-biomedical-to-participate-in-william-blair-46th-annual-growth-stock-conference Daily Healthcare St. Lucia en PressRelease 2026-05-21T11:05:00+00:00 Lifecore Biomedical to Participate in William Blair 46th Annual Growth Stock Conference https://ml.globenewswire.com/media/ca940278-cc18-4a3f-93b7-d8a034c998c9/small/lifecore-corporate-logo-2c-png.png https://www.dailyhealthcarestlucia.com/article/914040763-the-human-layer-in-weight-management-what-optavia-s-coaching-model-is-built-to-do Daily Healthcare St. Lucia en PressRelease 2026-05-21T11:00:00+00:00 The Human Layer in Weight Management: What OPTAVIA's Coaching Model Is Built to Do https://ml.globenewswire.com/media/71842691-8451-4b00-bdc5-6fd621c7675f/small/medifast-logo-jpg-jpg.jpg https://www.dailyhealthcarestlucia.com/article/914040779-weight-loss-coaching-vs-app-only-programs-what-published-research-shows-about-long-term-outcomes Daily Healthcare St. Lucia en PressRelease 2026-05-21T11:00:00+00:00 Weight Loss Coaching vs. App-Only Programs: What Published Research Shows About Long-Term Outcomes https://ml.globenewswire.com/media/71842691-8451-4b00-bdc5-6fd621c7675f/small/medifast-logo-jpg-jpg.jpg https://www.dailyhealthcarestlucia.com/article/914040971-vitacore-announces-world-first-custom-fit-cpap-mask-following-health-canada-mdl-approval Daily Healthcare St. Lucia en PressRelease 2026-05-21T11:00:00+00:00 Vitacore Announces World-First Custom-Fit CPAP Mask Following Health Canada MDL Approval https://ml.globenewswire.com/media/MDgyNzY5NDUtN2ZiNi00MjM0LTg2NTUtZTUyMjczOGIwZGUyLTEzMjM1MzAtMjAyNi0wNS0yMS1lbg==/tiny/VITACORE-INDUSTRIES.png https://www.dailyhealthcarestlucia.com/article/914041006-zen-leaf-dispensaries-mark-10-year-las-vegas-anniversary-with-all-in-at-10-community-focused-celebrations-may-21st-may-30th Daily Healthcare St. Lucia en PressRelease 2026-05-21T11:00:00+00:00 Zen Leaf Dispensaries Mark 10-Year Las Vegas Anniversary with “All-in-at-10” Community-Focused Celebrations May 21st-May 30th https://ml.globenewswire.com/media/18f2c9e0-d960-440b-a51f-b7d7ea7c9e08/small/verano-company-logo-png.png https://www.dailyhealthcarestlucia.com/article/914041014-picard-medical-syncardia-reports-first-quarter-2026-financial-results Daily Healthcare St. Lucia en PressRelease 2026-05-21T11:00:00+00:00 Picard Medical / SynCardia Reports First Quarter 2026 Financial Results https://ml.globenewswire.com/media/93c733bb-b54a-41af-856b-6d01c1f724a2/small/syncardia-x-picard-email-signature-2025-1-png.png https://www.dailyhealthcarestlucia.com/article/914041184-hemab-therapeutics-reports-first-quarter-2026-financial-results Daily Healthcare St. Lucia en PressRelease 2026-05-21T11:00:00+00:00 Hemab Therapeutics Reports First Quarter 2026 Financial Results https://ml.globenewswire.com/media/c5d70227-b7a8-4280-bd6b-389252a2e5b3/small/hemab-logo-jpg.jpg https://www.dailyhealthcarestlucia.com/article/914041799-materials-industry-sees-216-billion-in-strategic-investments-as-ai-infrastructure-drives-next-generation-material-innovation Daily Healthcare St. Lucia en PressRelease 2026-05-21T10:51:43+00:00 Materials Industry Sees $216 Billion in Strategic Investments as AI Infrastructure Drives Next-Generation Material Innovation https://ml.globenewswire.com/media/d0c282b6-d496-45a8-a941-33fa5c3e824c/small/bcc-logo-1200-630-png.png https://www.dailyhealthcarestlucia.com/article/914041775-immix-biopharma-announces-pricing-of-150-million-underwritten-offering-of-common-stock Daily Healthcare St. Lucia en PressRelease 2026-05-21T10:30:00+00:00 Immix Biopharma Announces Pricing of $150 Million Underwritten Offering of Common Stock https://ml.globenewswire.com/media/b46d5687-65de-44df-81d5-e36f2665d8e7/small/immix-logonew-gray-png.png https://www.dailyhealthcarestlucia.com/article/914041782-junshi-biosciences-announces-approval-of-toripalimab-nda-for-the-1st-line-treatment-of-her2-expressing-urothelial-carcinoma Daily Healthcare St. Lucia en PressRelease 2026-05-21T10:28:24+00:00 Junshi Biosciences Announces Approval of Toripalimab NDA for the 1st-line treatment of HER2 Expressing Urothelial Carcinoma https://ml.globenewswire.com/media/815f9c91-bb76-4c14-b3e9-0685275600cc/small/junshi-topalliance-logo-png.png https://www.dailyhealthcarestlucia.com/article/914041778-slimtide-examined-2026-consumer-focused-analysis-of-ingredients-claims-and-label-transparency Daily Healthcare St. Lucia en PressRelease 2026-05-21T10:27:12+00:00 SlimTide Examined: 2026 Consumer-Focused Analysis of Ingredients, Claims, and Label Transparency https://ml.globenewswire.com/Resource/Download/3aac0b62-b6c8-4d77-a567-fe8561a7e8e6/image1.png https://www.dailyhealthcarestlucia.com/article/914041772-javatide-examined-2026-analysis-of-ingredients-profile-dosage-accuracy-and-metabolic-support-claims Daily Healthcare St. Lucia en PressRelease 2026-05-21T10:00:30+00:00 JavaTide Examined: 2026 Analysis of Ingredients Profile, Dosage Accuracy, and Metabolic Support Claims https://ml.globenewswire.com/Resource/Download/04a28d95-9954-4b07-bd8e-8b94252baa21/javatide-facts.png https://www.dailyhealthcarestlucia.com/article/914041026-biodesix-to-participate-in-upcoming-investor-conferences Daily Healthcare St. Lucia en PressRelease 2026-05-21T10:00:00+00:00 Biodesix to Participate in Upcoming Investor Conferences https://ml.globenewswire.com/media/b2fd8e3c-ff04-47d9-938d-93c9c961ccc3/small/bdsx-logo-1200x240-png.png https://www.dailyhealthcarestlucia.com/article/914041761-immix-biopharma-announces-95-complete-response-rate-in-interim-update-from-relapsed-refractory-al-amyloidosis-clinical-trial-nexicart-2 Daily Healthcare St. Lucia en PressRelease 2026-05-21T10:00:00+00:00 Immix Biopharma Announces 95% Complete Response Rate in Interim Update From relapsed/refractory AL Amyloidosis Clinical Trial NEXICART-2 https://ml.globenewswire.com/media/b46d5687-65de-44df-81d5-e36f2665d8e7/small/immix-logonew-gray-png.png https://www.dailyhealthcarestlucia.com/article/914041764-hutchmed-and-innovent-jointly-announce-nmpa-approval-for-elunate-fruquintinib-in-combination-with-tyvyt-sintilimab-injection-for-the-treatment Daily Healthcare St. Lucia en PressRelease 2026-05-21T10:00:00+00:00 HUTCHMED and Innovent Jointly Announce NMPA Approval for ELUNATE® (Fruquintinib) in Combination with TYVYT® (Sintilimab Injection) for the Treatment of Patients with Locally Advanced or Metastatic Renal Cell Carcinoma https://ml.globenewswire.com/media/085957ad-3bec-49ee-b13e-39961b83c7be/small/hutchmed-small-spaced-1000x305-whitebgd-png.png https://www.dailyhealthcarestlucia.com/article/914016473-hanmi-pharmaceutical-partners-with-organon-to-export-combination-therapies-to-southeast-asia Daily Healthcare St. Lucia en PressRelease 2026-05-21T09:06:12+00:00 Hanmi Pharmaceutical Partners with Organon to Export Combination Therapies to Southeast Asia https://ml.globenewswire.com/media/b62e29c9-0e09-4dad-9cb8-6e47fb8415db/medium/signing-ceremony-strategic-partnership-agreement-between-han.png https://www.dailyhealthcarestlucia.com/article/914016456-concept-life-sciences-partners-with-openbench-to-deliver-success-based-drug-discovery-services-for-early-stage-biotech Daily Healthcare St. Lucia en PressRelease 2026-05-21T08:00:00+00:00 Concept Life Sciences Partners with OpenBench to Deliver Success-Based Drug Discovery Services for Early-Stage Biotech https://ml.globenewswire.com/media/eceda892-09d6-4e5a-a744-6b396a975b79/small/concept-life-sciences-600x450-jpg.jpg https://www.dailyhealthcarestlucia.com/article/914016427-orion-pharma-to-present-its-first-clinical-data-from-phase-1-2-teades-trial-of-tead-inhibitor-odm-212-at-the-2026-asco-annual-meeting Daily Healthcare St. Lucia en PressRelease 2026-05-21T07:30:00+00:00 Orion Pharma to present its first clinical data from Phase 1/2 TEADES trial of TEAD inhibitor ODM-212 at the 2026 ASCO® Annual Meeting https://ml-eu.globenewswire.com/media/9e6a027a-eb6c-4e34-993e-b8295e6d598d/small/orionpharma-rgb-press-releases-jpg.jpg https://www.dailyhealthcarestlucia.com/article/914016430-orion-pharma-julkistaa-ensimm-isi-kliinisi-tuloksia-faasi-1-2-teades-tutkimuksesta-odm-212-molekyylill-tead-est-j-2026-asco-vuosikokouksessa Daily Healthcare St. Lucia en PressRelease 2026-05-21T07:30:00+00:00 Orion Pharma julkistaa ensimmäisiä kliinisiä tuloksia Faasi 1/2 TEADES-tutkimuksesta ODM-212-molekyylillä (TEAD-estäjä) 2026 ASCO®-vuosikokouksessa https://ml-eu.globenewswire.com/media/9e6a027a-eb6c-4e34-993e-b8295e6d598d/small/ https://www.dailyhealthcarestlucia.com/article/913991973-nanobiotix-announces-temporary-trading-halt-of-its-ordinary-shares-on-euronext-paris Daily Healthcare St. Lucia en PressRelease 2026-05-21T06:30:00+00:00 Nanobiotix Announces Temporary Trading Halt of Its Ordinary Shares on Euronext Paris https://ml.globenewswire.com/media/36fb7b98-27d7-46cb-b989-fa31626657b8/small/nanobiotix-logo-jpg.jpg https://www.dailyhealthcarestlucia.com/article/913991978-nanobiotix-annonce-la-suspension-temporaire-du-cours-de-ses-actions-ordinaires-sur-euronext-paris Daily Healthcare St. Lucia en PressRelease 2026-05-21T06:30:00+00:00 Nanobiotix annonce la suspension temporaire du cours de ses actions ordinaires sur Euronext Paris https://ml.globenewswire.com/media/36fb7b98-27d7-46cb-b989-fa31626657b8/small/nanobiotix-logo-jpg.jpg https://www.dailyhealthcarestlucia.com/article/913991911-infex-therapeutics-announces-positive-phase-iia-results-for-resp-x-in-non-cystic-fibrosis-bronchiectasis-patients-colonised-with-pseudomonas Daily Healthcare St. Lucia en PressRelease 2026-05-21T06:00:00+00:00 Infex Therapeutics announces positive Phase IIa results for RESP-X in non-cystic fibrosis bronchiectasis patients colonised with Pseudomonas aeruginosa https://ml-eu.globenewswire.com/media/7e6719ab-feb1-4eb3-93c1-acca0cc4a3a1/small/infex-logo-png.png https://www.dailyhealthcarestlucia.com/article/913965589-sifts-microplastic-binding-supplement-claims-evaluated-the-chitosan-fiber-formula-for-daily-microplastic-particle-exposure-support Daily Healthcare St. Lucia en PressRelease 2026-05-21T02:03:16+00:00 Sifts Microplastic Binding Supplement Claims Evaluated: The Chitosan Fiber Formula for Daily Microplastic Particle Exposure Support https://zingfast.com/wp-content/uploads/2026/05/Sifts-Microplastic-Binding-Supplement.jpg https://www.dailyhealthcarestlucia.com/article/913965583-neurozen-under-investigation-critical-assessment-reveals-shocking-consumer-report-details-disclosed Daily Healthcare St. Lucia en PressRelease 2026-05-21T01:09:36+00:00 NeuroZen Under Investigation - Critical Assessment Reveals Shocking Consumer Report Details Disclosed https://zingfast.com/wp-content/uploads/2026/05/NeuroZen.jpg https://www.dailyhealthcarestlucia.com/article/913938070-relay-therapeutics-announces-pricing-of-public-offering-of-common-stock Daily Healthcare St. Lucia en PressRelease 2026-05-21T00:21:22+00:00 Relay Therapeutics Announces Pricing of Public Offering of Common Stock https://ml.globenewswire.com/media/079b6db5-ce81-4a81-9cde-d97f86c569ae/small/logo-banner-small-png.png https://www.dailyhealthcarestlucia.com/article/913910039-dyne-therapeutics-reports-inducement-grants-under-nasdaq-listing-rule-5635-c-4 Daily Healthcare St. Lucia en PressRelease 2026-05-20T21:30:00+00:00 Dyne Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) https://ml.globenewswire.com/media/2aa597a4-9b5c-4f0c-9ada-c5e06fa7d4de/small/dynelogo-r-final-full-color-rgb-jpg.jpg https://www.dailyhealthcarestlucia.com/article/913910072-johns-hopkins-health-plans-awards-60-000-to-maryland-and-virginia-organizations Daily Healthcare St. Lucia en PressRelease 2026-05-20T20:42:03+00:00 Johns Hopkins Health Plans Awards $60,000 to Maryland and Virginia Organizations https://ml.globenewswire.com/media/404affac-e9f4-456a-93bd-0ee405e6de49/small/johns-hopkins-logo-jpg.jpg https://www.dailyhealthcarestlucia.com/article/913910059-strongest-phentermine-alternatives-2026-what-otc-options-are-commonly-compared-to-phentermine-phenq-formulation-assessment-using-the-scale-9 Daily Healthcare St. Lucia en PressRelease 2026-05-20T20:31:51+00:00 Strongest Phentermine Alternatives 2026: What OTC Options Are Commonly Compared to Phentermine? PhenQ Formulation Assessment Using the SCALE-9 Evaluation Model https://ml.globenewswire.com/media/e5837328-83d5-4070-b167-275f236652e0/medium/phenq.png https://www.dailyhealthcarestlucia.com/article/913909512-information-on-the-total-number-of-voting-rights-and-shares Daily Healthcare St. Lucia en PressRelease 2026-05-20T20:30:00+00:00 Information on the total number of voting rights and shares https://ml-eu.globenewswire.com/media/a71f8653-a2aa-46a0-ad48-7eb6b9091673/small/logo-nyxoah-rgb-png.png https://www.dailyhealthcarestlucia.com/article/913909526-informations-sur-le-nombre-total-de-droits-de-vote-et-d-actions Daily Healthcare St. Lucia en PressRelease 2026-05-20T20:30:00+00:00 Informations sur le nombre total de droits de vote et d'actions https://ml-eu.globenewswire.com/media/a71f8653-a2aa-46a0-ad48-7eb6b9091673/small/ https://www.dailyhealthcarestlucia.com/article/913909554-l-assembl-e-g-n-rale-mixte-de-cellectis-se-tiendra-le-le-25-juin-2026 Daily Healthcare St. Lucia en PressRelease 2026-05-20T20:30:00+00:00 L’Assemblée Générale Mixte de Cellectis se tiendra le le 25 juin 2026 https://ml.globenewswire.com/media/a84ce25b-a774-4635-9b79-d45241f5decc/small/cellectis-logo-png.png https://www.dailyhealthcarestlucia.com/article/913909559-cellectis-annual-shareholders-general-meeting-to-be-held-on-june-25-2026 Daily Healthcare St. Lucia en PressRelease 2026-05-20T20:30:00+00:00 Cellectis’ Annual Shareholders General Meeting to be Held on June 25, 2026 https://ml.globenewswire.com/media/a84ce25b-a774-4635-9b79-d45241f5decc/small/cellectis-logo-png.png https://www.dailyhealthcarestlucia.com/article/913909611-cvrx-to-present-at-the-william-blair-46th-annual-growth-stock-conference Daily Healthcare St. Lucia en PressRelease 2026-05-20T20:30:00+00:00 CVRx to Present at the William Blair 46th Annual Growth Stock Conference https://ml.globenewswire.com/media/04c4feba-7841-4ac8-8ca5-6c03be383a0e/small/cvrx-outsmart-the-heart-logo-rgb-blue-png.png https://www.dailyhealthcarestlucia.com/article/913909902-palvella-therapeutics-presents-new-selva-and-toiva-data-at-the-2026-international-society-for-the-study-of-vascular-anomalies-world-congress Daily Healthcare St. Lucia en PressRelease 2026-05-20T20:30:00+00:00 Palvella Therapeutics Presents New SELVA and TOIVA Data at the 2026 International Society for the Study of Vascular Anomalies World Congress Supporting QTORIN™ Rapamycin as a Potential First-in-Disease Therapy for Multiple Serious, Rare Vascular… https://ml.globenewswire.com/media/83fd569b-5e6c-46ad-882a-6430f8ab755a/small/palvella-2025-logo-new-jpg.jpg https://www.dailyhealthcarestlucia.com/article/913910043-lemaitre-to-participate-at-upcoming-investor-conferences-in-june Daily Healthcare St. Lucia en PressRelease 2026-05-20T20:25:14+00:00 LeMaitre to Participate at Upcoming Investor Conferences in June https://ml.globenewswire.com/media/8b8755b7-6f04-4650-9c94-0a2d0654fd49/small/lemaitre-2color-rgb-jpg.jpg https://www.dailyhealthcarestlucia.com/article/913910006-bioadaptives-launches-myndsystem-website-the-first-supplement-platform-designed-to-support-both-daytime-cognitive-performance-and-overnight-brain Daily Healthcare St. Lucia en PressRelease 2026-05-20T20:15:53+00:00 BioAdaptives Launches MyndSystem™ Website — The First Supplement Platform Designed to Support Both Daytime Cognitive Performance and Overnight Brain Recovery https://ml.globenewswire.com/media/ad289631-6a2e-4b27-bc43-6b7ac688a537/small/bioadaptives-logo-jpg.jpg https://www.dailyhealthcarestlucia.com/article/913909569-dentsply-sirona-to-participate-in-the-2026-stifel-jaws-paws-conference Daily Healthcare St. Lucia en PressRelease 2026-05-20T20:15:00+00:00 Dentsply Sirona to Participate in the 2026 Stifel Jaws & Paws Conference https://ml.globenewswire.com/media/91e36dfa-44e3-4905-a186-3a988bd67ab8/small/dentsply-sirona-grey-80-black-rgb-jpg.JPG https://www.dailyhealthcarestlucia.com/article/913909891-vivos-therapeutics-reports-first-quarter-2026-financial-results-and-provides-operational-update Daily Healthcare St. Lucia en PressRelease 2026-05-20T20:10:00+00:00 Vivos Therapeutics Reports First Quarter 2026 Financial Results and Provides Operational Update https://ml.globenewswire.com/media/22d07f60-2e17-421d-bbc3-748c2402061e/small/picture2-jpg.JPG https://www.dailyhealthcarestlucia.com/article/913909551-ceribell-to-participate-in-the-william-blair-46th-annual-growth-stock-conference Daily Healthcare St. Lucia en PressRelease 2026-05-20T20:05:00+00:00 Ceribell to Participate in the William Blair 46th Annual Growth Stock Conference https://ml.globenewswire.com/media/937c5c00-41f8-45ff-b294-5f9c3f6ab2cf/small/cbll-square-logo-500x500-png.png https://www.dailyhealthcarestlucia.com/article/913909630-equillium-to-host-virtual-investor-event-to-share-new-insights-into-the-aryl-hydrocarbon-receptor-ahr-and-mir-124-axis Daily Healthcare St. Lucia en PressRelease 2026-05-20T20:05:00+00:00 Equillium to Host Virtual Investor Event to Share New Insights into the Aryl Hydrocarbon Receptor (AhR) and miR-124 Axis https://ml.globenewswire.com/media/14ce766d-e697-461f-a27c-c1ee49c0eeff/small/equillium-logo-360x180-jpg.jpg https://www.dailyhealthcarestlucia.com/article/913909669-rapport-therapeutics-to-participate-in-the-jefferies-global-healthcare-conference-and-goldman-sachs-47th-annual-global-healthcare-conference Daily Healthcare St. Lucia en PressRelease 2026-05-20T20:05:00+00:00 Rapport Therapeutics to Participate in the Jefferies Global Healthcare Conference and Goldman Sachs 47th Annual Global Healthcare Conference https://ml.globenewswire.com/media/7777ee9b-f88b-4a59-a668-d81520f9d32c/small/rapport-logo-color-rgb-png.png https://www.dailyhealthcarestlucia.com/article/913909676-longeveron-issues-letter-to-stockholders-highlighting-corporate-strategy-strategic-partnering-approach-and-2026-key-priorities Daily Healthcare St. Lucia en PressRelease 2026-05-20T20:05:00+00:00 Longeveron Issues Letter to Stockholders Highlighting Corporate Strategy, Strategic Partnering Approach and 2026 Key Priorities https://ml.globenewswire.com/media/cde71c09-a5f1-424d-837b-80f8786d82a5/medium/stephen-willard.jpg https://www.dailyhealthcarestlucia.com/article/913909854-20-20-biolabs-reports-first-quarter-2026-financial-results-and-recent-operational-progress Daily Healthcare St. Lucia en PressRelease 2026-05-20T20:05:00+00:00 20/20 BioLabs Reports First Quarter 2026 Financial Results and Recent Operational Progress https://ml.globenewswire.com/media/bcaf95ca-9983-408c-bc61-646e4ee2f925/small/2020-biolabs-logo-png.png https://www.dailyhealthcarestlucia.com/article/913909893-eledon-pharmaceuticals-to-present-new-long-term-data-from-phase-2-bestow-trial-of-tegoprubart-for-the-prevention-of-rejection-in-kidney Daily Healthcare St. Lucia en PressRelease 2026-05-20T20:05:00+00:00 Eledon Pharmaceuticals to Present New Long-Term Data from Phase 2 BESTOW Trial of Tegoprubart for the Prevention of Rejection in Kidney Transplantation at American Transplant Congress https://ml.globenewswire.com/media/5e2f90ec-c9a5-4fcd-99c8-2c8c838ac033/small/eledon-logo-1230-png.png https://www.dailyhealthcarestlucia.com/article/913909828-corvus-pharmaceuticals-to-present-at-the-2026-jefferies-global-healthcare-conference-and-goldman-sachs-47th-annual-global-healthcare-conference Daily Healthcare St. Lucia en PressRelease 2026-05-20T20:01:00+00:00 Corvus Pharmaceuticals to Present at the 2026 Jefferies Global Healthcare Conference and Goldman Sachs 47th Annual Global Healthcare Conference https://ml.globenewswire.com/media/d05c16d1-5c24-4242-84b5-aea3951ca251/small/corvus-logo-large-jpg.jpg https://www.dailyhealthcarestlucia.com/article/913909540-cytokinetics-to-hold-annual-meeting-of-stockholders Daily Healthcare St. Lucia en PressRelease 2026-05-20T20:00:00+00:00 Cytokinetics to Hold Annual Meeting of Stockholders https://ml.globenewswire.com/media/52e2be9f-e9e3-43af-a747-123fdcac4253/small/cytokinetics-png.png https://www.dailyhealthcarestlucia.com/article/913909871-clinical-trials-day-gains-national-recognition-through-first-ever-u-s-proclamation-initiative Daily Healthcare St. Lucia en PressRelease 2026-05-20T19:29:46+00:00 Clinical Trials Day Gains National Recognition Through First-Ever U.S. Proclamation Initiative https://ml.globenewswire.com/media/NDkyZDdmMzQtZjIzMi00OTUwLTlkMjYtYzkzNTc1ZWNkMmE5LTUwMDE1NDYzNi0yMDI2LTA1LTIwLWVu/tiny/Association-of-Clinical-Resear.png https://www.dailyhealthcarestlucia.com/article/913883552-aim-immunotech-announces-2-4-million-financing-including-concurrent-registered-direct-offering-and-private-placement Daily Healthcare St. Lucia en PressRelease 2026-05-20T19:02:14+00:00 AIM ImmunoTech Announces $2.4 Million Financing, Including Concurrent Registered Direct Offering and Private Placement https://ml.globenewswire.com/media/8e85b83b-047f-4f99-9c51-1aa232ffe9bb/small/aimlogo-jpg.jpg https://www.dailyhealthcarestlucia.com/article/913883546-jupiter-neurosciences-announces-pricing-of-2-0-million-registered-direct-offering Daily Healthcare St. Lucia en PressRelease 2026-05-20T18:38:00+00:00 Jupiter Neurosciences Announces Pricing of $2.0 Million Registered Direct Offering https://ml.globenewswire.com/media/4e829d7e-ecf6-46ad-98fe-479755d626e1/small/image-png.png https://www.dailyhealthcarestlucia.com/article/913883542-iafns-and-academy-of-nutrition-and-dietetics-publish-guidance-to-help-practitioners-navigate-questions-around-highly-processed-foods Daily Healthcare St. Lucia en PressRelease 2026-05-20T18:08:52+00:00 IAFNS and Academy of Nutrition and Dietetics Publish Guidance to Help Practitioners Navigate Questions Around Highly Processed Foods https://ml.globenewswire.com/media/N2NjZWY5OGUtNTM4Mi00MzBiLTk5OTItNDM2YTE5MTVjZDZhLTEyNzAxODMtMjAyNi0wNS0yMC1lbg==/tiny/Academy-of-Nutrition-and-Diete.png https://www.dailyhealthcarestlucia.com/article/913883514-fda-warns-retailers-selling-illegal-tobacco-products-that-look-like-everyday-products Daily Healthcare St. Lucia en PressRelease 2026-05-20T17:29:33+00:00 FDA Warns Retailers Selling Illegal Tobacco Products That Look Like Everyday Products https://ml.globenewswire.com/media/MTdmNzZjMDEtMWVmOS00ZmZiLThlNGQtODY1ODdlZTBlY2JhLTUwMDE1NDE1NC0yMDI2LTA1LTIwLWVu/tiny/FDA.png https://www.dailyhealthcarestlucia.com/article/913859717-leafwell-advances-medical-cannabis-as-clinically-validated-solution-for-cancer-related-symptoms-and-chronic-pain-supports-employer-sponsored-mental Daily Healthcare St. Lucia en PressRelease 2026-05-20T15:17:15+00:00 Leafwell Advances Medical Cannabis as Clinically Validated Solution for Cancer-Related Symptoms and Chronic Pain, Supports Employer-Sponsored Mental Health Benefits https://ml.globenewswire.com/media/86423433-b118-4b2b-8f83-a8cc0d68098c/small/leafwell-logo-green-and-black-2021-png.png https://www.dailyhealthcarestlucia.com/article/913859700-mink-therapeutics-reports-new-data-on-agent-797-an-allo-inkt-cell-therapy-at-ats-2026-simultaneously-published-in-clinical-immunology-communications Daily Healthcare St. Lucia en PressRelease 2026-05-20T15:07:14+00:00 MiNK Therapeutics Reports New Data on agenT-797, an allo-iNKT Cell Therapy at ATS 2026; Simultaneously Published in Clinical Immunology Communications https://ml.globenewswire.com/media/6aa8e960-515a-40d6-9894-39ca47f5c84e/small/mink-logo-loyal-blue-and-light-blue-png.png https://www.dailyhealthcarestlucia.com/article/913859093-ama-unveils-infographic-to-help-patients-safely-navigate-ai-in-healthcare Daily Healthcare St. Lucia en PressRelease 2026-05-20T14:30:00+00:00 AMA Unveils Infographic to Help Patients Safely Navigate AI in Healthcare https://ml.globenewswire.com/media/YWI5ZWE1ZGItMGJhMC00ZmU3LWIwZjctYTdlNzVmNTIxMjJkLTEwOTg0MDUtMjAyNi0wNS0yMC1lbg==/tiny/American-Medical-Association.png https://www.dailyhealthcarestlucia.com/article/913858606-how-to-boost-testosterone-after-40-safe-testosterone-boosters-for-men-over-40-and-50-for-muscle-growth-energy-stamina-and-performance-in-2026 Daily Healthcare St. Lucia en PressRelease 2026-05-20T14:19:09+00:00 How To Boost Testosterone After 40?| Safe Testosterone Boosters for Men Over 40 and 50 For Muscle Growth, Energy, Stamina and Performance in 2026 – Launched By Testoprime https://ml-eu.globenewswire.com/Resource/Download/329f05ae-17dd-42ae-88e0-9b7ff687ebcf/image2.png https://www.dailyhealthcarestlucia.com/article/913858813-ronald-mcdonald-house-new-england-launches-brand-revitalization-deepening-its-mission-to-keep-families-close Daily Healthcare St. Lucia en PressRelease 2026-05-20T14:00:00+00:00 Ronald McDonald House New England Launches Brand Revitalization, Deepening its Mission to Keep Families Close https://pressranger.s3.us-west-1.amazonaws.com/3291515/rmh_newengland_logo_hrz_color_rgb_pos.png https://www.dailyhealthcarestlucia.com/article/913859084-regional-health-properties-reports-first-quarter-2026-results Daily Healthcare St. Lucia en PressRelease 2026-05-20T13:41:00+00:00 Regional Health Properties Reports First Quarter 2026 Results https://ml.globenewswire.com/media/bfd51062-4a60-4cf0-9f2f-a4b109b52e4a/small/logo-jpg.jpg https://www.dailyhealthcarestlucia.com/article/913835677-tru-1-by-bluegenes-launches-to-advance-precision-health-through-smarter-genetic-insights Daily Healthcare St. Lucia en PressRelease 2026-05-20T13:15:00+00:00 Tru-1 By BlueGenes Launches to Advance Precision Health Through Smarter Genetic Insights https://ml.globenewswire.com/media/ZWViMTQwZTctODE3YS00NGIwLTk0NzgtYjIyYzQzNzYwOWM3LTUwMDEzNTI2MC0yMDI2LTA1LTIwLWVu/tiny/BlueGenesLab.png https://www.dailyhealthcarestlucia.com/article/913834406-new-studies-show-adherence-to-monthly-injectable-buprenorphine-is-associated-with-relapse-reduction-and-lower-healthcare-utilization Daily Healthcare St. Lucia en PressRelease 2026-05-20T13:00:00+00:00 New Studies Show Adherence to Monthly Injectable Buprenorphine is Associated with Relapse Reduction and Lower Healthcare Utilization https://ml-eu.globenewswire.com/media/42de3285-90ea-4020-a3ad-25f71026b41a/small/indivior-logo-jpg.jpg https://www.dailyhealthcarestlucia.com/article/913835033-alzheimer-s-research-sites-honor-national-clinical-trials-day Daily Healthcare St. Lucia en PressRelease 2026-05-20T13:00:00+00:00  Alzheimer’s Research Sites Honor National Clinical Trials Day https://ml.globenewswire.com/media/79913531-32c1-476a-8d22-887b6775a191/small/gap-logo-1708444397196-png.png https://www.dailyhealthcarestlucia.com/article/913835062-biostem-technologies-announces-notice-of-allowance-for-four-u-s-design-patent-applications-covering-fenestrated-human-placental-allografts-and-one Daily Healthcare St. Lucia en PressRelease 2026-05-20T13:00:00+00:00 BioStem Technologies Announces Notice of Allowance for Four U.S. Design Patent Applications Covering Fenestrated Human Placental Allografts and One European Patent https://ml.globenewswire.com/media/f4323fdf-217c-4eaf-94ad-897e8158965b/small/biostem-technologies-logo.png https://www.dailyhealthcarestlucia.com/article/913835675-aeroflow-urology-donates-to-national-diaper-bank-network-and-united-way-to-improve-national-health-equity Daily Healthcare St. Lucia en PressRelease 2026-05-20T13:00:00+00:00 Aeroflow Urology Donates to National Diaper Bank Network and United Way to Improve National Health Equity https://ml.globenewswire.com/media/f0030ee9-d8c8-4321-a610-4bb1ed358418/small/aeroflow-health-png.png https://www.dailyhealthcarestlucia.com/article/913835697-jenavalve-appoints-tonya-porter-as-vice-president-of-regulatory-affairs Daily Healthcare St. Lucia en PressRelease 2026-05-20T13:00:00+00:00 JenaValve Appoints Tonya Porter as Vice President of Regulatory Affairs https://ml.globenewswire.com/media/a1ab2446-a463-4b8f-bc18-26a5ca117176/small/jv-logo-h-rgb-l-1607-png.png https://www.dailyhealthcarestlucia.com/article/913836064-codexis-highlights-stereochemistry-advances-for-scalable-rna-manufacturing-at-tides-usa Daily Healthcare St. Lucia en PressRelease 2026-05-20T13:00:00+00:00 Codexis highlights stereochemistry advances for scalable RNA manufacturing at TIDES USA https://ml.globenewswire.com/media/ebbfa755-c2db-4783-aace-43c700ba3369/small/codexis-logo-september-2023-png.png